JP6860832B2 - Drug container - Google Patents

Description

The present invention, all SANYO relates tablet feeder to take out the drug by a predetermined amount weighed relates medicament container is detachable to the main unit of the tablet feeder. The drug feeder described above is preferably used as a device for supplying powder to a powder distribution device that distributes powder. The tablet feeder described above distributes the powdered medicine in the powdered medicine dispensing device, Ru suitable der Yet device incorporated in powdered medicine packing apparatus having a function of individually packaged this.

In recent years, large hospitals and large-scale pharmacies have introduced powder dispensing devices and drug dispensing devices having a powder packaging function. Here, the powder packaging device is a device that individually packages powders and the like for each dose. If a powder packaging device is used, most of the work of packaging powders and the like in doses can be automated.
The powder packaging device 200 disclosed in Patent Document 1 is a device for individually packaging powders for each dose, and as shown in FIG. 49, the drug supply device 201, the powder distribution device 202, and the drug packaging are inside. It has a device 203.
The drug supply device 201 disclosed in Patent Document 1 is composed of a charging hopper 205 and a powder feeder 206 as shown in FIGS. 49 and 50.
As shown in FIG. 50, the powder feeder 206 is provided with two piezoelectric elements 207 and 208 under the trough 210 to vibrate the trough 210.

As shown in FIG. 49, the powder distribution device 202 is composed of a distribution plate 212 and a scraping device 215. The distribution dish 212 has a groove 216 having an arcuate cross section and an annular view in a plan view. The distribution plate 212 is rotated at a constant speed by the motor 219.
The scraping device 215 has a disc 217 that moves up and down and rotates, and the scraping plate 218 is provided on the disc 217.

As shown in FIG. 49, the drug packaging device 203 is composed of a packaging hopper 220 and a packaging device 221.

Next, the procedure in the case of packaging the powder using the powder packaging device 200 will be described.
The work of packaging the powder is performed by the pharmacist operating the powder packaging device 200 according to the doctor's prescription. That is, the pharmacist confirms the doctor's prescription and takes out the medicine bottle containing the prescribed powder from the medicine rack (not shown). Then, the total weight of the prescribed specific powder is weighed using a scale such as a balance.
That is, it is a powdered drug to be taken three times a day, and when 1.0 gram is prescribed and the drug for 20 days is prescribed, (1.0 × 3 × 20 = 60) gram. Powder is taken out. More specifically, the container is placed on the scale and tare is performed, the powder is removed from the medicine bottle using a spatula, the powder is placed in the container on the scale, and 60 grams of powder is weighed out.

Then, 60 grams of the weighed powder is charged into the charging hopper 205 of the drug supply device 201.
At the same time, the piezoelectric elements 207 and 208 (FIG. 50) of the powder feeder 206 are energized to vibrate the trough 210, and the distribution pan 212 is further rotated at about 20 to 30 revolutions per minute.
The powder charged into the charging hopper 205 falls from the opening at the lower end of the charging hopper 205 to the trough 210 of the powder feeder 206. Then, as the trough 210 vibrates, the powder slowly moves to the tip side and is rectified. Further, while moving on the trough 210, rectification progresses, and the flow of the drug becomes a laminar flow state. That is, the distribution of the drug in the cross section in the direction orthogonal to the flow is constant, and the distance that the drug travels per unit time is also constant. As a result, 60 grams of powder is evenly dispersed and slowly moves towards the tip at a constant rate per hour.
Finally, the powder that moves at the head reaches the tip of the trough 210, and the powder that moves at the head falls from the tip of the trough 210 into the groove 216 of the distribution plate 212. Further, the powdered medicine that follows will fall into the distribution plate 212 by a certain amount per hour. Finally, the last powder drops into the distribution dish 212, and all 60 grams of powder enters the groove 216.

On the other hand, since the distribution plate 212 is rotating at a predetermined speed, the powder falling from the trough 210 is evenly distributed in the groove 216 of the distribution plate 212.
That is, the powder feeder 206 gradually drops the powder into the distribution plate 212, and the distribution plate 212 rotates at a constant speed, so that the powder is evenly distributed in the groove 216 of the distribution plate 212.

When the dropping of the powder onto the distribution plate 212 is completed, the rotation of the distribution plate 212 is temporarily stopped. Then, after that, the disc 217 of the scraping device 215 is dropped into the groove 216 of the distribution plate 212. After that, the distribution plate 212 is rotated by an angle according to the number of distributions. In the previous example, since 60 grams of powder is divided into 60 packets, the distribution dish 212 is rotated by (60/360) degrees, and the powder is placed on the front side of the disk 217 by (60/360) degrees. Gather. Then, the disk 217 is rotated, and the powder for (60/360) degrees is scraped out of the distribution plate 212 by the scraping plate 218 and put into the packaging hopper 220. The powdered medicine dropped from the packaging hopper 220 is packaged in the packaging device 221.

Japanese Unexamined Patent Publication No. 2000-85703

By using the powder packaging device 200 disclosed in Patent Document 1, most of the work of packaging the powder in doses can be automated.
However, it cannot be said that the powdered powder packaging device 200 of the prior art is a device that can completely automate the packaging of powdered medicine because there are still steps that must be relied on manually.
That is, in the prior art powder packaging device 200, it is essential that the pharmacist takes out a medicine bottle containing a desired powder from the medicine rack and weighs a predetermined amount of powder from the medicine bottle.

Therefore, the present invention pays attention to the above-mentioned problems of the prior art, and an object of the present invention is to provide a drug container capable of more highly automating the work of weighing powder by attaching it to the main body device of the drug feeder. Is what you do.

One aspect of the present invention developed to solve the above problems is a drug container used for a drug feeder provided with a main body device, and the drug container is detachable from the main body device of the drug feeder. The drug container is vibrated by the main body device, and the drug container has a drug storage section for storing the drug and a drug discharge section for discharging the drug to the outside, and the drug discharge section communicates inside and outside. There is a region that serves as a passage for the drug between the drug storage portion and the opening portion of the drug discharge portion, and the tip side of the region is narrowed, and the region and the drug storage portion are narrowed. There is a constriction opening between the parts and the movable lid part, and the state where the drug discharge part is closed and the state where the movable lid part is pressed by the pressing piece to open the drug discharge part. By vibrating the drug container, the drug in the drug reservoir passes through the constriction opening and enters a region serving as a passage for the drug, and the drug is stratified. , A drug container in which the drug is discharged from the drug discharge section.
In a preferred embodiment, the movable lid portion swings about a shaft formed by a shaft or a shaft piece located below the upper end of the movable lid portion and above the opening portion. A drug container in which the upper end of the movable lid portion swings around the shaft portion and moves to the drug storage portion side when the drug discharge portion is opened.
In a more preferable embodiment, when the drug container is provided with a shielding wall for sealing the drug above the opening portion and the drug discharge portion is opened, the upper end of the movable lid portion is the said. It is a drug container that swings around the shaft and moves to the shielding wall side.
In a more preferable embodiment, a rectifying member is provided inside, and the rectifying member is arranged at a position where a part or all of the drug passes when the internal drug is moved to the drug discharging portion side, and the rectifying member is provided. The region functions as a lead-out path portion, and the drug is promoted to be laminarized in the lead-out path portion, and the drug whose laminar flow is promoted is moved along the lower surface of the peripheral wall of the container body to move the opening. The drug container according to any one of claims 1 to 3, wherein the drug container is discharged from a portion.
A more preferred embodiment is a drug container in which the movable lid portion has a knob portion, and when the grip portion is pushed by the pressing piece, the movable lid portion is opened.
In a more preferred embodiment, the movable lid portion is connected to the knob portion arranged at one end and the knob portion at the other end, and the drug discharge portion is in a closed state and an open state. It is a drug container having and.
A more preferred embodiment is a drug container in which the movable lid portion has a bearing portion that receives a shaft portion or a shaft portion formed of a shaft piece between the holding plate portion and the knob portion.
In a more preferred embodiment, the drug container is placed on a container shelf for storing the drug container at the time of storage, and the drug container is placed on the drug container from the container shelf by a container moving means for moving the drug container. This is a drug container in which the holding plate portion is opened when the knob portion is pushed by the pressing piece when the main body device is moved to the main body device and installed in the horizontal posture.
A more preferable embodiment is that the drug container is a drug container that is placed in a vertical position or an inclined position on a container shelf during storage.
A more preferable embodiment is a drug container provided with a transport iron plate portion capable of being attracted by an electromagnet at a position on the upper surface with respect to a horizontal posture.
A more preferred embodiment is a drug container in which the movable lid portion is maintained in a closed state by engaging with a leaf spring.
A more preferable embodiment is a drug container having an opening on the upper surface side with reference to the horizontal posture, and the drug can be charged into the inside through the opening.
A more preferred embodiment is a position in which a coiled member is provided inside, and the coiled member crosses the inside of the coiled member when part or all of the drug is moved to the drug discharging portion side. It is a drug container provided in.
Another aspect of the present invention developed to solve the above problems is a drug feeder composed of a drug container and a main body device, and the drug container is removable from the main body device. The drug container has a drug discharge section for discharging the drug, and the main body device includes a shaking table, a vibrating means for vibrating the shaking table, a container holding means for temporarily fixing the drug container to the shaking table, and a drug. It has a weight measuring means for directly or indirectly measuring the weight of the container, the drug container is placed on a shaking table, the drug container is fixed to the shaking table by the container holding means, and the shaking table is vibrated to vibrate the drug. It is a drug feeder characterized in that a drug is discharged little by little from a discharge unit and the discharge amount of the drug can be detected by a weight measuring means.

In the drug feeder of the related invention described above , the drug container is fixed to the shaking table, and the drug container is brought into direct contact with the shaking table. By vibrating the shaking table in this state, the whole or part of the drug container can be vibrated. Therefore, the drug in the drug container slowly moves to the drug discharge section side, the drug is rectified, the flow is laminarized, and the drug is discharged from the drug discharge section.
Further, since the drug feeder of the related invention is equipped with a weight measuring means, it is possible to detect the amount of the drug discharged and to automate the work of weighing out the powder or the like.

It is desirable that the drug feeder of the related invention described above is provided with a plurality of contact sensors for detecting whether or not the drug container is in contact with the shaking table.

Since the drug feeder of this embodiment is provided with a plurality of contact sensors for detecting whether or not the drug container is in contact with the shaking table, the posture of the drug container with respect to the shaking table can be confirmed. Therefore, the drug feeder of the related invention can keep the variation in the posture of the drug container with respect to the shaking table within a certain range.
That is, in the drug feeder of this embodiment, the drug container is brought into direct contact with the shaking table, and the shaking table is vibrated to vibrate the drug container to move the drug. Must be within range.
For example, in order to discharge a certain amount of drug per unit time from the drug container by vibration, it is desirable that the drug container is in a horizontal posture. Assuming that the drug container is attached to the shaking table with the drug discharge portion side of the drug container tilted upward, it is difficult for the drug to move to the drug discharge section side even if vibration is applied.
If the axis of the drug container and the center line of the shaking table are misaligned or intersect with each other, the drug will not be in a laminar flow state when the drug is moved by vibration, and the drug will flow turbulently. It will be in a state. That is, the direction in which the shaking table tries to move the drug and the direction of the flow path of the powder or the like regulated by the peripheral wall of the drug container are different, and the distribution of the drug in the cross section intersecting the flow direction varies.
On the other hand, in this embodiment, since the variation in the posture of the drug container with respect to the shaking table can be kept within a certain range, the distribution of the drug in the cross section intersecting the flow direction becomes uniform. Therefore, according to the related invention , the movement of the drug is likely to be rectified, and a laminar flow state is likely to occur. Therefore, according to the drug feeder of this embodiment, the variation in the amount of discharge per unit time is small.

In the drug feeder, it is desirable that the drug container is partially or wholly made of a magnetic material, and the container holding means has a magnet.
The magnet is preferably an electromagnet.

In this embodiment, an electromagnet is used as the container holding means. Therefore, the drug container can be attracted and held on the shaking table simply by energizing the electromagnet. Further, when the energization of the electromagnet is stopped, the drug container can be separated from the shaking table.

The magnet is provided on the shaking table, and there is an elastic member between the shaking table and the magnet. When the drug container is attracted to the magnet, the magnet moves relative to the shaking table due to the attractive force of the magnet. It is desirable that the magnet and the drug container and the shaking table and the drug container come into contact with each other.
The magnet is preferably an electromagnet.

In the drug feeder of the related invention , when the drug container is attracted to the electromagnet or the like, the electromagnet or the like moves relative to the shaking table due to the attractive force of the electromagnet or the like, and the electromagnet or the like and the drug container or the shaking table and the drug container come into contact with each other. be able to. Therefore, in the drug feeder of the related invention , the adhesion between the shaking table and the drug container is high, and the vibration of the shaking table can be accurately transmitted to the drug container.

The drug container is partially or wholly made of a magnetic material, and the container holding means has a permanent magnet and an electromagnet. At least the drug container is fixed to the shaking table by the magnetic force of the permanent magnet, and the electromagnet is energized to energize the permanent magnet. It is recommended that the drug feeder be configured to release the fixation of the drug container to the shaking table by generating a magnetic force that cancels out.

In the drug feeder of this embodiment, the container holding means has a permanent magnet and an electromagnet, and the drug container is fixed to the shaking table by at least the magnetic force of the permanent magnet. Therefore, when the drug container is attached to the main body device, the amount of electricity applied to the electromagnet is small. If a configuration is adopted in which the drug container is fixed to the shaking table only by the magnetic force of the permanent magnet, it is not necessary to energize the electromagnet while the drug container is fixed to the shaking table. Therefore, the electromagnet does not generate heat and the drug in the drug container is not heated. Further, since it is not necessary to energize the electromagnet while the drug container is fixed to the shaking table, the power consumption is small. Therefore, the power consumption of the entire drug feeder is small and the amount of heat generated is small, so that the drug is less likely to be affected.

It is desirable that the drug feeder is provided with a cooling means for cooling the main body device.

The chemical feeder has a vibration isolator, a vibration isolator between the vibration isolator and the vibration isolator, and the weight measuring means detects the total weight of the vibration isolator, and the weight measuring means. It is desirable that the amount of the drug discharged is detected by the change in the detected weight.

In the drug feeder of this embodiment, the weight measuring means detects the total weight of the vibration isolator. Further, the vibration table is vibrated by the vibration isolating means, but since there is a vibration isolating member between the vibrating means and the vibration isolating table, the vibration of the vibrating means is not easily transmitted to the vibration isolating table.
In the drug feeder of this embodiment, since the total weight of the vibration isolator is detected by the weight measuring means as described above, the weight measuring means is not easily affected by vibration and can accurately measure the weight of the drug container or the like. ..

An intermediate table and a vibration isolator that supports the intermediate table via a vibration isolator are provided, and the vibration means, the shaking table, and the container holding means are mounted on the intermediate table, and the weight measuring means is It is desirable that the drug feeder detects the total weight of the vibration isolator and detects the amount of the drug discharged by the change in the detection weight of the weight measuring means.

Also in the drug feeder of this embodiment, the weight measuring means detects the total weight of the vibration isolator. That is, the weight measuring means measures all the weights of the shaking table, the drug container on the shaking table, the intermediate table, the vibration isolator, the vibrating means, and the container holding means.
Further, the vibrating table is vibrated by the vibrating means, but all the vibrating members are placed on the intermediate table, and the vibration isolator supports the intermediate table via the vibration isolating member. Vibration of the intermediate table etc. is not easily transmitted to the vibration isolation table.
In the drug feeder of this embodiment, since the total weight of the vibration isolator is detected by the weight measuring means as described above, the weight measuring means is not easily affected by vibration and can accurately measure the weight of the drug container or the like. ..

The drug container has a drug storage section for storing the drug, has a stenosis opening and a lead-out path section between the drug storage section and the drug discharge section, and the drug container is placed on a shaking table. A drug feeder that vibrates the drug container, discharges the drug in the drug storage section from the stenosis opening into the lead-out path, further moves the drug in the lead-out path toward the drug discharge section, and drops the drug from the drug discharge section. Is desirable.

It can be said that the drug feeder of this embodiment serves the role of the hopper 205 and the role of the trough 210 in the conventional drug feeder in the drug container.
That is, the drug container adopted in this embodiment has a drug storage section for storing the drug, and has a stenotic opening between the drug storage section and the drug discharge section. Therefore, the flow rate of the drug that moves to the drug discharge portion side due to vibration is regulated at the stenosis opening, and a trigger for laminar flow is created.
That is, it can be said that the powdered medicine or the like in the drug container is randomly incorporated in the drug storage section and is in an irregular state in the drug storage section. Then, the drug container receives vibration, and the drug inside tries to move to the drug discharging portion side, but the drug is randomly contained as described above, and the movement of the drug is turbulent.
The drug moves to the stenotic opening, during which time the drug undergoes vibration and changes from a random state to a unidirectionally oriented state. Furthermore, when the drug passes through the stenotic opening, the amount of passage per unit time is regulated, so that the pulsation of the drug flow is suppressed and the drug flow is rectified.
Then, the powdered medicine or the like discharged from the stenosis opening proceeds through the lead-out path. The powdered medicine or the like is rectified as it goes through the lead-out path, laminar flow progresses, and it falls from the drug discharge part in a highly laminarized state.

A rectifying member is provided in the drug container, the drug container is placed on a shaking table, the drug container is vibrated to move the drug in the drug container to the drug discharge part side, and a part or all of the drug is moved at the time of movement. Is a drug feeder that passes through the rectifying member.

Since the rectifying member is provided in the drug feeder of this embodiment, the flow of the drug can be made uniform.

It is desirable that the rectifying member described above be replaceable.

In the drug feeder of this embodiment, the rectifying member can be replaced according to the properties of the drug.

A coil-shaped member is provided in the drug container, the drug container is placed on a shaking table, the drug container is vibrated to move the drug in the drug container to the drug discharge part side, and a part of the drug or a part of the drug is moved. It is desirable that all of them are drug feeders that traverse the inside of the coiled member.

In the drug feeder of the related invention , the coiled member functions as a rectifying member. In addition, the powdered powder mass can be disintegrated and returned to the original powder form.

It is desirable that the drug feeder is provided with a desiccant container in the drug container, and the desiccant is arranged in the desiccant container.

According to the drug feeder of this embodiment, it is possible to prevent the drug from becoming damp and to smoothly discharge the drug.

The original weight, which is the weight of the drug container before the drug is discharged, is measured by the weight measuring means, and when the shaking table is vibrated and the drug is discharged little by little from the drug discharging section, the weight of the drug container is measured by the weight measuring means. It is a drug feeder with a weighing function that monitors and stops the vibration of the shaking table when the current weight, which is the current weight of the drug container, matches or substantially matches the value obtained by subtracting the target emission amount from the original weight. Is desirable.

As for the means for measuring the weight of the drug container, the measurement of the weight of the drug container may be direct or indirect. That is, only the weight of the drug container may be directly measured, or the weight including the device such as the shaking table may be measured.
In the drug feeder of the related invention, the original weight, which is the weight of the drug container before discharging the drug, and the current weight, which is the current weight of the drug container, are utilized, and the current weight is calculated by subtracting the target discharge amount from the original weight. When they match, the vibration of the shaking table is stopped. Alternatively, in consideration of the weight of the drug in the middle of falling, the vibration of the shaking table is stopped when the current weight is slightly smaller than the value obtained by subtracting the target emission amount from the original weight and substantially matches. Therefore, after the target amount of the drug is discharged, the vibration of the shaking table is stopped and the discharge of the drug is stopped.

It is desirable that the drug feeder can change the vibration pattern of the shaking table.

The drug feeder of this embodiment can vibrate the shaking table with an appropriate vibration pattern according to the properties of the drug and the total discharge amount.

When the drug feeder vibrates the shaking table to discharge a predetermined amount of the drug from the drug discharge unit little by little, it is desirable that the vibration pattern at the initial stage of discharge and the vibration pattern after that can be different. ..

According to this aspect, in the process of discharging the drug, the vibration pattern can be changed between the initial stage of discharge and the time when the discharge state is stable. Therefore, the drug can be stably discharged.

The drug feeder of this embodiment has a plurality of types of vibration patterns at the initial stage of discharge when a predetermined amount of drug is discharged little by little from the drug discharge section by vibrating the shaking table, and depending on the type and / or the total discharge amount of the drug. It is desirable that the vibration pattern at the initial stage of discharge is changed.

The drug feeder may have an opening on the upper surface side of the drug container with reference to the posture attached to the main body device, and the drug may be charged into the drug container through the opening.

The drug feeder of this embodiment is suitable for packaging a drug that is infrequently prescribed. The drug feeder of this embodiment is also suitable for packaging drugs that are not suitable for storage in a drug container.

Further, a desirable drug dispensing device includes a container storage unit for storing a plurality of drug containers, the above-mentioned drug feeder, and a container moving means for taking out a predetermined drug container from the container storage unit and placing it on the shaking table of the drug feeder. It is characterized by that.

According to the drug dispensing device of this embodiment, the process of selecting the drug container and placing it on the shaking table of the drug feeder is also automated.

The drug container has a container-side engaging portion on the bottom side of the drug container at a position not in contact with the shaking table based on the posture attached to the main body device, and the container storage portion is a storage unit that engages the engaging portion. It is desirable to have a side engagement.

It is desirable that the drug dispensing device of the related invention related to the present invention has a powder dispensing device for distributing powder, and the drug is charged into the powder dispensing device by the drug feeder described above.

The drug dispensing device of this embodiment includes, for example, a powder dispensing device as described in the prior art. Therefore, the action of improving the work efficiency of the powder dispensing device and the action of the drug feeder of the related invention described above can be combined to achieve a high level of automation, and the powder can be packaged with high efficiency.

Double measurement having a plurality of weight measuring means, discharging a drug from a drug container using a drug feeder, and then measuring the weight of the drug container again by a weight measuring means other than the weight measuring means of the drug feeder. Performing the process It is desirable to have a drug dispensing device.

In the drug dispensing device of the related invention, after the drug is dispensed, the weight of the drug container is remeasured using another weight measuring means. Therefore, even if there is a problem with the weight measuring means of the drug feeder, we apologize. The prescribed amount of drug is not packaged. Furthermore, if there is a large difference in the measured values due to remeasurement, it is possible to detect a failure of the weight measuring means.

It has a weight member whose weight is known, the weight member is placed in a predetermined weight member standby position, the weight member is moved by the container moving means and placed on a drug feeder, and the weight measuring means is inspected. It is desirable that the drug dispensing device is capable of the above.

According to this aspect, an abnormality of the weight measuring means can be detected. Also, the drug can always be weighed accurately.

By attaching the drug container of the present invention to the main body device of the drug feeder, the work of weighing out powders and the like can be automatically performed. Therefore, the work performed by the pharmacist can be reduced, and there is an effect that a high degree of automation can be realized. It also has the effect of reducing human error, which was unavoidable in the prior art.

It is a mechanism diagram which simplifies and explains the structure of the drug feeder of the embodiment of this invention, and shows the state which the main body apparatus and the drug container are at different positions. It is a mechanism diagram explaining the drug feeder of FIG. 1, and shows the state which the drug container is fixed to the main body apparatus. It is a mechanism diagram explaining the drug feeder of FIG. 1, and shows the state when the drug container is fixed to the main body apparatus, and the shaking table is vibrated. FIG. 5 is a perspective view of a drug feeder according to an embodiment of the present invention, which uses the drug container of the first embodiment and has a structure similar to that of a practical product. It is a perspective view of the drug container of the 1st form. It is an exploded perspective view of the drug container of 1st form. FIG. 5 is a sectional view taken along the line AA of the drug container of the first form shown in FIG. (A) is a front view of the rectifying member used in the drug container of the first form, (b) is a side view thereof, and (c) is a reference view of (b) observed from the direction of arrow A. FIG. 5 is a perspective view of a drug feeder according to an embodiment of the present invention, which uses the drug container of the second embodiment and has a structure similar to that of a practical product. It is a perspective view of the drug container of the 2nd form. FIG. 5 is a perspective view of a drug feeder according to an embodiment of the present invention, which uses the drug container of the third embodiment and has a structure similar to that of a practical product. It is a perspective view of the drug container of the 3rd form. It is an exploded perspective view of the drug container of the 3rd form. It is an exploded perspective view of the lid member of the medicine container of the 3rd form. It is a perspective view which observed the lid member of the medicine container of 3rd form from the diagonally lower side with respect to the horizontal posture. It is a top view which observed the lid member of the medicine container of 3rd form from above with respect to a horizontal posture. It is a perspective view which shows the state which removed the movable lid part from the medicine container of 3rd form. It is a perspective view of the main part of the medicine container of the 3rd form in the state which the movable lid part is open. It is a perspective view of the main body apparatus adopted in the drug feeder of FIG. 4, FIG. 9, and FIG. It is an exploded perspective view of the main body apparatus of FIG. It is sectional drawing of the shaking table shown in the exploded perspective view of FIG. It is the central cross-sectional perspective view of the intermediate stand shown in the exploded perspective view of FIG. 20, and the perspective view which shows the vibration-proof table, the vibration-proof member, and the weight measuring means, and it is shown by releasing these in the height direction. FIG. 5 is a cross-sectional perspective view at a position off the center of the intermediate table shown in the exploded perspective view of FIG. FIG. 19 is a sectional view taken along the line AA of the main body device of FIG. FIG. 19 is a cross-sectional perspective view of the main body device of FIG. (A) is a schematic perspective view for explaining the relative positional relationship between the main body device and the drug container immediately before the drug container is placed on the shaking table of the main body device in the drug feeder of FIG. 11 (b). Is an explanatory diagram for explaining the deviation of the central axes of the two. (A) is a schematic perspective view for explaining the relative positional relationship between the main body device and the drug container immediately after the drug container is placed on the shaking table of the main body device in the drug feeder of FIG. 11 (b). Is an explanatory diagram for explaining the deviation of the central axes of the two. In the drug feeder of FIG. 11, the drug container is placed on the shaking table of the main body device, and the relationship between the main body device and the drug container in a state where the electromagnet is energized is illustrated. FIG. It is a perspective view explaining the relationship, and (b) is an explanatory view explaining the deviation of the central axis of both. It is an external view of the drug dispensing device in which the drug feeder of FIG. 11 is installed. It is the schematic of the drug dispensing device of FIG. 29. It is a perspective view which shows the relationship between the drug container of FIG. 12 and the hand part adopted by the drug dispensing device of FIG. It is a flowchart which shows the operation of the drug dispensing apparatus of FIG. It is a perspective view which shows the relationship between the drug container of FIG. 12 and the hand part adopted in the drug dispensing device of a modified example. It is a perspective view of the drug container of the 4th form. It is an exploded perspective view of the drug container of the 4th form. It is a perspective view which observed the lid member of the medicine container of 4th form from the back side. It is a perspective view which removed the comb-shaped rectifying member from the state of FIG. 36. It is an exploded perspective view of the lid member of the medicine container of 4th form. It is sectional drawing of the medicine container of 4th form, (a) shows the state which the movable lid part is closed, and (b) shows the state that the movable lid part is open. It is a partially enlarged sectional view of the medicine container of 4th form, (a) shows the state at the time of use, and (b) shows the state at the time of removing a lid member. It is a partially enlarged sectional view of the medicine container of 4th form, and shows the state which the lid member was removed. It is sectional drawing of the medicine container of 4th form, and shows the behavior at the time of discharging a medicine inside. It is a perspective view of the drug container of the 5th form. It is a perspective view of the drug container of the 5th form, and shows the state at the time of adding a drug by a usual method. It is a perspective view of the drug container of the 5th form, and shows the state when the drug is charged by another method. It is a mechanism diagram explaining the drug feeder of another embodiment. It is a perspective view which shows an example of the container storage part. It is a perspective view which shows another example of a container storage part. It is a block diagram of the powder packaging apparatus disclosed in Patent Document 1. It is a block diagram of the powder feeder disclosed in Patent Document 1.

Hereinafter, embodiments of the present invention will be described, but in embodiments having a shape close to the actual design, the members are intricate and the structure is complicated. Therefore, in order to facilitate the understanding of the invention, the mechanical features and operating principles of the embodiments will be described first. Then, after that, a detailed description of the specific embodiment will be given.
The drug feeder 1 of the present embodiment constitutes a part of a powder dispensing device or a drug dispensing device having a powder dispensing function, and as shown in FIG. 1, the vicinity of the distribution dish 212 of the powder distribution device 202. Will be installed in.
The configuration of the drug feeder 1 of the present embodiment is represented by a mechanical diagram as shown in FIGS. 1 to 3. That is, the drug feeder 1 is composed of a drug container 2 and a main body device 3.

Further, the drug container 2 described above is composed of a container body 5, an iron plate portion 6, and a rectifying member 7.
The container body 5 is a vertically long container made of resin, and one end in the longitudinal direction is open to form a drug discharge section 8.
Since the drug container 2 is placed in a vertical posture or an inclined posture as shown in FIG. 1 during storage and is installed in a horizontal posture as shown in FIGS. 2 and 3 during use, the container body 5 is a drug serving as an opening surface. The surface facing the discharge unit 8 as a reference is referred to as a bottom surface 10, and the wall surface connecting the drug discharge unit 8 and the bottom surface 10 is referred to as a peripheral wall surface 11. Further, among the peripheral wall surfaces 11, the surface located on the bottom side, particularly when the peripheral wall surface is in a horizontal posture during use, is referred to as the peripheral wall surface lower surface 12.
The container body 5 has a storage space 15 (FIG. 2) surrounded by a bottom surface 10 and a peripheral wall surface 11, and only one surface thereof is an opening surface to form a drug discharge portion 8. Further, a protrusion 16 is provided on the outer peripheral surface side of the container body 5. The protrusion 16 projects downward when the container body 5 is in the horizontal posture, and is located near the bottom surface 10 of the container body 5. That is, the protrusion 16 hangs down at the position farthest from the drug discharging portion 8.

The iron plate portion 6 is a steel plate containing a magnetic material component such as ferrite. The iron plate portion 6 is an outer peripheral portion of the container main body 5 and is attached to the lower surface 12 of the peripheral wall.

The rectifying member 7 is a comb-shaped plate (the comb shape is not shown in FIGS. 1, 2 and 3). The rectifying member 7 is inside the container body 5, and a gap (narrowing opening 13) is formed only between the rectifying member 7 and the lower surface 12 side of the peripheral wall. The rectifying member 7 is inclined so that the end on the narrowing opening 13 side faces the inside of the container body 5 (bottom surface 10 side).
The rectifying member 7 is removable from the container body 5. Further, the illustrated rectifying member 7 is only an example, and can be replaced according to the properties of the drug.

In the present embodiment, the inside of the container body 5 is partitioned by the rectifying member 7, and the bottom surface 10 side of the rectifying member 7 functions as the powder storage unit 17. Further, the region on the side of the drug discharge portion 8 with the rectifying member 7 on the lower surface 12 of the peripheral wall as a boundary functions as the lead-out path portion 18.

Next, the main body device 3 will be described.
As shown in FIGS. 1 to 3, the main body device 3 is composed of a vibrating table 20, vibration means 21a and 21b, an intermediate table 22, a vibration isolating table 23, a weight measuring means 25, and a foundation member 26 from the top.

Hereinafter, the description will be given sequentially. The shaking table 20 is a block-shaped mounting table, and electromagnets 30a and 30b are built in the shaking table 20. That is, the shaking table 20 is provided with magnet mounting holes 28a and 28b, and the electromagnets 30a and 30b are built in the magnet mounting holes 28a and 28b.
Further, the electromagnets 30a and 30b are fixed to the bottoms of the magnet mounting holes 28a and 28b via elastic bodies 32a and 32b. Therefore, the electromagnets 30a and 30b have a slight degree of freedom with respect to the shaking table 20.
As shown in FIG. 1, the suction portions (tips of the iron core) 31a and 31b of the electromagnets 30a and 30b are located lower than the upper surface of the shaking table 20.
Contact sensors 33a, b, c, d are provided at the four corners of the shaking table 20 on both outer sides of the electromagnets 30a and 30b. Specifically, the contact sensors 33a, b, c, and d are electrodes.
Further, a vibration detection sensor 35 is attached to one side surface of the shaking table 20.

The vibrating means 21a and 21b are piezoelectric elements and have a plate shape.
Although the intermediate table 22 and the vibration isolation table 23 actually have complicated shapes as described later, they are mechanically merely tables, and in FIGS. 1 to 3, they are simply illustrated in a flat plate shape. There is.
The weight measuring means 25 is a known load cell, and has an upper installation surface 36 and a lower installation surface 37, both of which are at offset positions.
Although the foundation member 26 actually has a complicated shape as described later, it is only a table mechanically, and is simply shown as a flat plate in FIGS. 1 to 3.

Next, the positional relationship of each component of the main body device 3 will be described. In the main body device 3, as shown in FIGS. 1 to 3, vibration means 21a and 21b are provided between the shaking table 20 and the intermediate table 22. That is, as shown in FIG. 1, the shaking table 20 and the intermediate table 22 face each other, and one end of the shaking table 20 and one end of the intermediate table 22 are connected by the vibrating means 21a. Further, the other end of the shaking table 20 and the other end of the intermediate table 22 are connected by the vibrating means 21b.
In the present embodiment, there is no member other than the above-mentioned vibrating means 21a and 21b that connects between the shaking table 20 and the intermediate table 22. Therefore, the vibrating table 20 has a structure in which the vibrating table 20 is hollowly supported from the intermediate table 22 by the vibrating means 21a and 21b.

A vibration isolation table 23 is arranged below the intermediate table 22, and a vibration isolation member 40 is interposed between the intermediate table 22 and the vibration isolation table 23. The vibration-damping member 40 is a member having both a vibration-damping function and a vibration-damping function, and is a combination of a spring 38 and a vibration-damping rubber (not shown).
In the present embodiment, there is no member other than the vibration-proof member 40 described above that connects between the intermediate table 22 and the vibration-proof table 23. Therefore, the intermediate base 22 has a structure in which the intermediate base 22 is hollowly supported from the vibration isolation base 23 by the vibration isolation member 40.

Further, a weight measuring means 25 is arranged below the vibration isolation table 23, and a foundation member 26 is further arranged below the weight measuring means 25.
In the weight measuring means 25, the upper installation surface 36 is connected to the lower surface of the vibration isolator 23, and the lower installation surface 37 of the weight measuring means 25 is attached to the foundation member 26.
As described above, since the upper installation surface 36 and the lower installation surface 37 are at offset positions, the intermediate portion of the weight measuring means 25 has a structure that is cantilevered with respect to the foundation member 26. The vibration isolator 23 is supported on the free end side.
In the present embodiment, there is no member other than the weight measuring means 25 described above that connects the vibration isolator 23 and the foundation member 26. Therefore, the vibration isolator 23 has a structure that is hollowly supported from the foundation member 26 by the weight measuring means 25.

Further, the foundation member 26 is attached to the vicinity of the distribution plate 212 of the powder distribution device 202 via the vibration isolator member 41.
Since the foundation member 26 is a base that supports the entire main body device 3 of the drug feeder 1, the main body device 3 is attached in the vicinity of the distribution dish 212 of the powder distribution device 202.

As described above, the drug feeder 1 of the present embodiment has a structure in which the vibrating table 20 is hollowly supported by the vibrating means 21a and 21b. Therefore, when the vibrating means 21a and 21b are vibrated, the vibrating means 21a and 21b are supported. The vibration is conducted to the shaking table 20, and the shaking table 20 vibrates.

Further, in the present embodiment, the weights of the shaking table 20, the vibrating means 21a and 21b, the intermediate table 22 and their accessories are all supported by the vibration isolating table 23. Further, the total weight of the vibration isolator 23 is supported by the upper installation surface 36 of the weight measuring means 25. Therefore, the weight of all the members on the weight measuring means 25 is mechanically applied to the upper installation surface 36 of the weight measuring means 25 as compared with the weight measuring means 25. Therefore, the weight measuring means 25 measures all the weights of the members above the weight measuring means 25. Therefore, in the present embodiment, when the drug container 2 is placed on the shaking table 20, the weight of the drug container 2 is indirectly measured.

Further, as described above, the shaking table 20 and the vibrating means 21a and 21b generate vibrations, but all the members that generate the vibrations are mounted on the intermediate table 22, and the intermediate table 22 and the vibration isolator table. Since the vibration isolator 40 is interposed between the vibration isolator 23, the vibrations of the vibrating table 20 and the vibrating means 21a and 21b are not easily transmitted to the vibration isolator 23.
In the present embodiment, since the weight measuring means 25 is connected to the vibration isolator 23, the weight measuring means 25 is less susceptible to the vibrations of the shaking table 20 and the vibrating means 21a and 21b, and has an accurate weight. Can be detected.
That is, in the present embodiment, since the vibration isolating member 40 is provided between the vibrating means 21a and 21b and the vibration isolating table 23, the weight measuring means 25 is not easily affected by vibration.
Further, the present embodiment includes an intermediate table 22 and a vibration isolator table 23 that supports the intermediate table 22 via a vibration isolator member 40, and the vibrating means 21a and 21b and the vibrating table 20 are placed on the intermediate table 22. Therefore, the weight measuring means 25 is not easily affected by vibration.

The drug feeder 1 of the present embodiment is composed of the drug container 2 and the main body device 3 as described above, but usually both are separate, and when the powdered drug is packaged, the two are combined. The drug feeder 1 is configured.
That is, as described above, the main body device 3 of the drug feeder 1 is fixed in the vicinity of the distribution dish 212 of the powder distribution device 202.
On the other hand, the drug container 2 is placed and stored on a container shelf (not shown) as shown in FIG. That is, the drug container 2 is filled with a predetermined powder, and is placed on a container shelf (not shown) in a vertical posture or an inclined posture (not shown) as shown in FIG. 1, for example.

The drug feeder 1 of the present embodiment constitutes a part of the powder dispensing device (or the overall shape of the drug dispensing device is not shown) as described above, and as shown in FIG. 1, the powder dispensing device 202 It is installed in the vicinity of the distribution plate 212. Another device that constitutes the powder packaging device is a robot (container moving means) 43 that conveys the drug container 2. The robot 43 has an XY table (not shown) and a hand 45 for grasping the drug container 2.
Further, the powder packaging device (the overall shape is not shown) includes a prescription reading means 46 for reading the prescription and a control device 47 for controlling the operation of each device.
The prescription reading means 46 is a device that reads the drug name, prescription amount, and other contents of the prescription drug described on the prescription.

Next, the function of the drug feeder 1 of the present embodiment will be described. Since the drug feeder 1 constitutes a part of the powder dispensing device (the overall shape is not shown), the operation of the drug feeder 1 will be described including the operation of the entire powder dispensing device.
In the present embodiment, as described above, the drug container 2 and the main body device 3 are separate, and when the powdered drug is packaged, both are combined to form the drug feeder 1.
That is, in the present embodiment, the drug container 2 is stored in a vertical posture or an inclined posture, and the powder is stored in the powder storage unit 17. In the present embodiment, as shown in FIG. 1, the drug container 2 is grasped by the hand 45 of the robot 43, the drug container 2 is moved, and the drug container 2 is placed on the main body device 3 as shown in FIG.
More specifically, as shown in FIG. 2, the drug container 2 is moved and its posture is changed. That is, the drug container 2 is moved to the vicinity of the main body device 3, and the drug container 2 is laid down in a horizontal posture and placed on the shaking table 20. At this time, as shown in FIG. 2, the posture is such that the lower surface 12 of the peripheral wall is on the bottom. That is, the iron plate portion 6 of the drug container 2 places the drug container 2 on the shaking table 20 in a posture facing the shaking table 20.

Then, the electromagnets 30a and 30b built in the shaking table 20 are energized. As a result, a magnetic force is generated in the electromagnets 30a and 30b, and the iron plate portion 6 of the drug container 2 is attracted to the suction portion (tip of the iron core) 31a and 31b on the shaking table 20 side.
In the present embodiment, the electromagnets 30a and 30b are fixed to the bottoms of the magnet mounting holes 28a and 28b via the elastic bodies 32a and 32b, and the electromagnets 30a and 30b have a slight degree of freedom with respect to the shaking table 20. Therefore, as shown in FIG. 2, the electromagnets 30a and 30b move slightly toward the iron plate portion 6, and the suction portions 31a and 31b are brought into close contact with the iron plate portion 6 of the drug container 2.
Further, due to the elasticity of the iron plate portion 6 of the drug container 2 and the shaking table 20 itself, these are slightly deformed and become familiar.
As a result, the iron plate portion 6 of the drug container 2 comes into close contact with the surface of the shaking table 20 and the electromagnets 30a and 30b.

Subsequently, in the present embodiment, the degree of adhesion between the drug container 2 and the shaking table 20 and the posture of the drug container 2 are confirmed.
Specifically, if the contact sensors 33a, b, c, d provided around the electromagnets 30a, 30b are energized and there is continuity between the contact sensors 33a, b, c, d, the drug container 2 is used. It is determined that the degree of adhesion of the shaking table 20 and the posture of the drug container 2 are normal. On the contrary, if there is no continuity between the contact sensors 33a, b, c, and d, the degree of adhesion between the drug container 2 and the shaking table 20 is insufficient, or the posture of the drug container 2 is abnormal.

That is, the contact sensors 33a, b, c, d are electrodes exposed on the surface of the shaking table 20. On the other hand, since the iron plate portion 6 is provided on the outer peripheral portion of the drug container 2 and the lower surface 12 of the peripheral wall, if the drug container 2 is in close contact with the shaking table 20 and the posture of the drug container 2 is normal. , The contact sensors 33a, b, c, d come into contact with the iron plate portion 6, and the contact sensors 33a, b, c, d conduct with each other via the iron plate portion 6.
On the contrary, if there is a problem such as insufficient adhesion between the drug container 2 and the shaking table 20, any or all of the contact sensors 33a, b, c, d do not come into contact with the iron plate portion 6, and the contact sensor Insulation is established between 33a, b, c, and d.

When it is confirmed that there is continuity between the contact sensors 33a, b, c, and d, the shaking table 20 is vibrated. More specifically, the vibrating means 21a and 21b are energized with a current of a constant frequency to generate vibration, and the vibration table 20 is vibrated by this vibration. The amplitude of the shaking table 20 is monitored by the vibration detection sensor 35, and the current frequencies input to the vibrating means 21a and 21b are changed so that the amplitude becomes large.
Further, before and after the start of vibration, the distribution plate 212 of the powder distribution device 202 is rotated.

Further, before and after the start of vibration, the weight of the drug container 2 is measured. The weight of the drug container 2 is obtained by subtracting a constant value from the weight detected by the weight measuring means 25. More specifically, the weight of the drug container 2 is obtained by subtracting the weight of the member above the weight measuring means 25 of the main body device 3 from the detected weight of the weight measuring means 25.
That is, in the weight measuring means 25, the weights of the shaking table 20, the vibrating means 21a and 21b, the intermediate table 22 and their accessories are all supported by the vibration isolator 23, and the weight measuring means 25 causes the vibration isolator 23 to be supported by the weight measuring means 25. Since the weight is measured, the weight measuring means 25 measures all the weights of the members above the weight measuring means 25.
Therefore, when the drug container 2 is placed on the shaking table 20, a value obtained by adding the weight of the drug container 2 to the weight of the shaking table 20 or the like is detected by the weight measuring means 25.
Since the weight of the shaking table 20 and the like is known here, the weight of the drug container 2 can be indirectly detected by subtracting the weight of the shaking table 20 and the like from the weight detected by the weight measuring means 25.
The weight of the drug container 2 immediately after being installed on the shaking table 20 is stored as the original weight G. The weight of the drug container 2 is constantly monitored. That is, the current weight of the drug container 2 is monitored as the current weight g.

When the shaking table 20 starts to vibrate, the drug container 2 vibrates. Here, in the present embodiment, the drug container 2 is firmly joined to the shaking table 20 by the electromagnets 30a and 30b, and the degree of adhesion to the shaking table 20 is high. Therefore, the drug container 2 is referred to as the shaking table 20. It vibrates at the same frequency. As a result, the powder stored in the powder storage unit 17 of the drug container 2 slowly moves toward the drug discharge unit 8.
When the shaking table 20 vibrates, the drug container 2 itself receives a force to move in the forward direction. However, in the present embodiment, a protrusion 16 is provided at the rear end of the drug container 2, and the protrusion 16 is provided. Is prevented from advancing the drug container 2 itself by coming into contact with a part of the shaking table 20 or the like. Therefore, the drug container 2 does not move, and only the powder inside moves.

The powder then reaches the constriction opening 13 formed by the site of the rectifying member 7. Since the height of the opening of the stenosis opening 13 is limited, the height of the powder that passes through the stenosis opening 13 is adjusted. That is, the powder flows through the lower surface 12 of the peripheral wall of the drug container 2 as if it were a river, but the height from the lower surface 12 of the peripheral wall to the upper part of the powder is aligned in the width direction.
The powdered drug that has passed through the stenosis opening 13 is discharged to the lead-out path portion 18. Then, the powder flows through the lead-out path portion 18 like the flow of a river, finally reaches the drug discharge section 8 of the drug container 2, falls like a waterfall, and enters the groove 216 of the distribution plate 212 below.

The fact that the powder is falling is confirmed by the weight reduction of the drug container 2. That is, in the present embodiment, the current weight of the drug container 2 continues to be monitored as the current weight g even when the powder is falling from the drug discharge section 8 of the drug container 2. Then, the original weight G of the drug container 2 immediately after being installed on the shaking table 20 is compared with the current weight g, and the amount of powder dropped H (G minus g) is constantly calculated.

Further, the vibration intensity of the shaking table 20 is fed back so that the falling amount h of the powder per unit time becomes constant. That is, if the amount of fall h per unit time is too small, the frequency of vibration is increased. On the contrary, if the amount of drop is too large, the frequency is lowered. Similarly, the magnitude of the amplitude is also fed back so that the amount of fall h per unit time is constant.
Then, when the total drop amount H of the powder reaches a desired weight, the vibration of the shaking table 20 is stopped.

After that, the rotation of the distribution plate 212 is stopped, the distribution plate 212 is rotated by an angle according to the number of distributions, and the powder is discharged to the outside of the distribution plate 212 by a scraping device (not shown), as in the prior art powder packaging device. It is scraped out and sent to the drug packaging device (not shown) on the latter stage.

Next, an embodiment of the present invention having a form closer to a practical design will be described. The drug feeder 50 described below has a member shape that is significantly different from the mechanical diagram shown in FIG. 1 in order to reduce the overall height, and although the assembly relationship of the parts is complicated, the basic structure of each member and the basic structure of each member and the assembly relationship are complicated. The function is the same as that of the previous embodiment. The components of the drug feeder 50 described below basically have all the functions of the drug feeder 1 described above. so that. Members that have different shapes but perform the same function shall be given the same number and name. Further, the description of the members and the like will be mainly described in the portion different from the previous embodiment, and the overlapping portion will be limited to a schematic description.

The drug feeder 50 having a shape close to the practical design is composed of the drug container 2 and the main body device 3 as in the previous embodiment (FIG. 4).
First, the structure of the drug container 2 will be described. In this embodiment, six types of drug containers 2A, 2B, 2C, 2D, 2E, and 2F are prepared according to the intended use.
That is, the drug container 2A (related invention) of the first form is a type in which the drug discharge section 8 has no lid as shown in FIG. The drug container 2B (related invention) of the second form is a two-sided open type as shown in FIG. 10, and when the drug discharge portion 8 has no lid and is in a horizontal posture, the portion corresponding to the top surface is greatly opened. It is a type that has been used. The drug container 2C of the third form is a closed type as shown in FIG. 12 and has a lid. The drug container 2D of the fourth form is a closed type as shown in FIG. 34 and has a lid. The drug container 2E of the fifth form is a closed type as shown in FIG. 43, has a lid, and has a large lid at a portion corresponding to the top surface and can be opened and closed.

Sequentially, the drug container 2A of the first form is composed of a container body 5, an iron plate portion 6, and a rectifying member 7, as shown in FIGS. 5 and 6.
The container body 5 is a vertically long container made of resin, and one end in the longitudinal direction is a drug discharging portion 8.
In the present embodiment, the cross-sectional shape of the container body 5 is hexagonal as shown in FIGS. 5 and 6. That is, there are six peripheral wall surfaces 11 of the container body 5, including the peripheral wall surface 12.
More specifically, the cross-sectional shape of the container body 5 is symmetrical with respect to the state in which the container body 5 is placed horizontally as shown in FIGS. 5 and 6. Then, as shown in FIGS. 5 and 6, there is a peripheral wall upper surface 51 facing the peripheral wall lower surface 12 with reference to a state in which the container body 5 is placed horizontally.
Further, as a surface connecting the upper surface 51 of the peripheral wall and the lower surface 12 of the peripheral wall, there are left and right vertical peripheral walls 52a and b, and left and right inclined peripheral walls 53a and b.
Therefore, based on the state of being placed horizontally as shown in FIGS. 5 and 6, the container body 5 is clockwise from the top, the upper surface 51 of the peripheral wall in the horizontal posture, the right vertical peripheral wall 52b in the vertical posture, and the right in the inclined posture. The shape is surrounded by a total of six surfaces: an inclined peripheral wall 53b, a horizontal peripheral wall lower surface 12, a left inclined peripheral wall 53a in an inclined posture, and a left vertical peripheral wall 52a in a vertical posture.
Therefore, in the present embodiment, the lower surface 12 of the peripheral wall through which the powder flows flows is smaller than the other surfaces. Further, in the present embodiment, the powder is easily collected from the other peripheral wall to the lower surface 12 of the peripheral wall.
Also in this embodiment, the protrusion 16 is provided on the outer peripheral surface side of the container body 5. The positions of the protrusions 16 and the like are the same as those in the previous embodiment, and when the container body 5 is in the horizontal posture, the protrusions 16 project downward.

The iron plate portion 6 is formed into a shape that matches a part of the peripheral wall lower surface 12 and the left and right inclined peripheral walls 53a and b.
That is, as shown in FIG. 6, the cross-sectional shape of the iron plate portion 6 is symmetrical, has a flat peripheral wall lower surface contact portion 55, and has inclined peripheral wall contact portions 56a and b on both sides thereof.
There is a certain angle between the peripheral wall lower surface contact portion 55 and the inclined peripheral wall contact portions 56a and b, and this angle is between the peripheral wall lower surface 12 of the container body 5 and the left and right inclined peripheral walls 53a and b. Is equal to the angle of.
The iron plate portion 6 is adhered to a portion on the outer peripheral surface side of the container body 5 corresponding to the lower surface 12 of the peripheral wall.

As shown in FIG. 8, the rectifying member 7 is formed of resin and is provided with a substantially square closing plate portion 57, a first comb-shaped portion 58, and a second comb-shaped portion 60. ..
The first comb-shaped portion 58 extends in an oblique direction from the vicinity of the lower side of the closing plate portion 57, and the free end side is divided into a plurality of parts to form a comb shape.
The second comb-shaped portion 60 extends obliquely rearward from the back surface of the closing plate portion 57, and the free end side is divided into a plurality of parts to form a comb shape.

The rectifying member 7 is inside the container body 5 as shown in FIGS. 5 and 7, and the free end side of the comb-shaped portions 58 and 60 is inclined toward the bottom surface 10. That is, the comb-shaped portions 58 and 60 of the rectifying member 7 are inclined so that the free end side is the inner side of the container body 5.
As shown in FIG. 7, a constriction opening 13 is formed between the free end of the first comb-shaped portion 58 and the lower surface 12 of the peripheral wall and between the free end of the second comb-shaped portion 60 and the lower surface 12 of the peripheral wall. The first and second comb-shaped portions 58 and 60 are inclined so that the end portion on the narrowing opening 13 side faces the inner side (bottom surface 10 side) of the container body 5.
Also in this embodiment, the inside of the container body 5 is partitioned by the rectifying member 7, and the bottom surface 10 side of the rectifying member 7 functions as the powder storage unit 17. Further, the region on the side of the drug discharge section 8 with the rectifying member 7 on the lower surface 12 of the peripheral wall as a boundary functions as the lead path section 18.

Next, a modified example of the drug container 2 will be described. In the explanation of each modification described below, B, C, D, E, and F shall be added to the same numbers for the members common to the drug container 2A and the parts exhibiting the common functions. Therefore, a detailed description will be omitted.
The second form of the drug container 2B will be described with reference to FIGS. 9 and 10. As shown in FIG. 10, the drug container 2B is a two-sided open type, and is a type in which the portion corresponding to the top surface is greatly opened when the drug discharge portion 8 is in a horizontal posture without a lid. That is, it can be said that the drug container 2B has the upper side of the drug container 2A of the first form removed. More simply, the drug container 2B lacks a portion corresponding to the upper surface 51 (FIG. 6) of the peripheral wall.
The drug container 2B is composed of a container body 5B, an iron plate portion 6B, and a rectifying member 7B, similarly to the drug container 2A of the first form described above.
The container body 5B is a vertically long and gutter-shaped container made of resin, and one end in the longitudinal direction is a drug discharge portion 8B.
In the present embodiment, the peripheral wall surface 11B of the container body 5B has five surfaces including the peripheral wall lower surface 12B.
More specifically, the cross-sectional shape of the container body 5B is symmetrical with respect to the state in which the container body 5B is placed horizontally as shown in FIG. Then, as shown in FIGS. 9 and 10, the side facing the lower surface 12B of the peripheral wall is open based on the state in which the container body 5B is placed horizontally.
Also in this embodiment, the protrusion 16B is provided on the outer peripheral surface side of the container body 5B. The position of the protrusion 16B and the like are the same as those in the previous embodiment, and when the container body 5B is in the horizontal posture, the protrusion 16B protrudes downward.

The iron plate portion 6B has the same shape as the iron plate portion 6 of the drug container 2A of the first form described above, and is formed into a shape that matches the lower surface 12B of the peripheral wall and the like.
The iron plate portion 6B is adhered to a portion on the outer peripheral surface side of the container body 5B and corresponding to the peripheral wall lower surface 12B.

The main portion of the rectifying member 7B is the same as that adopted in the drug container 2A of the first form described above, and the closing plate portion 57B, the first comb-shaped portion 58B, and the second comb-shaped portion (second comb) are used. The shape part does not appear in the drawing). However, the total height of the closing plate portion 57B is lower than that adopted in the drug container 2A of the first form described above.

Next, the drug container 2C of the third form will be described with reference to FIG. The drug container 2C is a closed type, and a lid member 120 is provided on the container body 5C.
That is, the drug container 2C is composed of a container body 5C, an iron plate portion 6C, and a lid member 120. Further, in the drug container 2C, a rectifying unit 7C (FIG. 13) is integrally provided on the rear end side of the lid member 120. The rectifying unit 7C has the same function as the rectifying members 7A and 7B described above, but is referred to as the rectifying unit 7C because it is a part of the lid member 120 as described later.
Further, the drug container 2C includes a transport iron plate portion 157.
The container body 5C is a vertically long container made of resin, and one end in the longitudinal direction is a drug discharging portion 8C. In this embodiment, the cross-sectional shape of the container body 5C is hexagonal as shown in FIGS. 11, 12, and 13. That is, there are six peripheral wall surfaces 11C of the container body 5C including the peripheral wall surface 12C.
More specifically, the cross-sectional shape of the container body 5C is symmetrical with respect to the state in which the container body 5C is placed horizontally as shown in FIG. Then, as shown in FIG. 13, there is a peripheral wall upper surface 51C facing the peripheral wall lower surface 12C with reference to a state in which the container body 5C is placed horizontally.
Further, there are left and right vertical peripheral walls 52aC and 52bC, and left and right inclined peripheral walls 53aC and 53bC as surfaces connecting the peripheral wall upper surface 51C and the peripheral wall lower surface 12C.

Therefore, based on the state of being placed horizontally as shown in FIG. 11, the container body 5C is clockwise from the top, the upper surface 51C of the peripheral wall in the horizontal posture, the right vertical peripheral wall 52bC in the vertical posture, and the inclined posture as shown in FIG. The shape is surrounded by a total of six surfaces: a right-sloping peripheral wall 53bC, a horizontal peripheral wall lower surface 12C, a left-sloping peripheral wall 53aC in an inclined posture, and a left vertical peripheral wall 52aC in a vertical posture.

However, in the present embodiment, the peripheral wall lower surface 12C is not a flat surface, and has a stepped portion 121 on the drug discharging portion 8 side as shown in FIGS. 12 and 13. That is, the drug discharging portion 8C side is lowered by one step with respect to the horizontal posture to form the lower step portion 122. In other words, the peripheral wall lower surface 12C is divided into an upper portion 123 and a lower portion 122 with the step portion 121 as a boundary.
Therefore, each wall connected to the lower surface 12C of the peripheral wall, that is, the right inclined peripheral wall 53bC in the inclined posture and the left inclined peripheral wall 53aC in the inclined posture, which are connected to the lower step portion 122, has a larger area than the other parts.
In the present embodiment, since the lower portion 122 is provided on the lower surface of the peripheral wall 12C on the side of the drug discharge portion 8C, the container body 5C has the drug discharge portion 8C side bulging downward.

Also in this embodiment, the protrusion 16C is provided on the outer peripheral surface side of the container body 5C. The positions of the protrusions 16C and the like are the same as those in the previous embodiment, and when the container body 5C is in the horizontal posture, the protrusions 16C project downward.

The iron plate portion 6C is formed into a shape that matches a part of the upper portion 123 of the peripheral wall lower surface 12C and the left and right inclined peripheral walls 53aC and 53bC connected thereto.
The iron plate portion 6C is adhered to a portion on the outer peripheral surface side of the container body 5C and corresponding to the upper portion 123 of the peripheral wall lower surface 12C.
As shown in FIGS. 11, 12, and 13, the transport iron plate portion 157 is provided on the upper surface 51C of the peripheral wall.

The lid member 120 is composed of a lid main body portion 125, a movable lid portion 134, and a rectifying coil 126. Further, a rectifying portion 7C is formed on the rear end side of the lid member 120 by a part of the lid member 120 and the rectifying coil 126.
The lid main body portion 125 has a frame portion 127 on the front surface side, and a coil support portion 128 and a comb-shaped rectifying portion 130 are provided on the rear surface side.

Further, the frame portion 127 on the front side has a portion that functions as a fixing frame 131 and a portion that functions as a contact frame 132.
That is, the frame portion 127 has a hexagonal front view similar to the cross-sectional shape of the container body 5C, and has an upper side 133, left and right vertical sides 135a and 135b, left and right inclined sides 136a and 136b, and a lower side 137 with reference to the horizontal posture. doing. The fixing frame 131 is formed by the upper side 133 and the left and right vertical sides 135a and 135b, and the contact frame 132 is formed by the left and right inclined sides 136a and 136b and the lower side 137.
That is, the inner circumferences of the upper side 133, which is the three sides constituting the fixing frame 131, and the left and right vertical sides 135a, 135b are equal to the inner circumference shape of the drug discharge portion 8C of the container body 5C, and are fitted with the drug discharge portion 8C of the container body 5C. It is possible.

That is, the position and length of the upper side 133 of the fixing frame 131 are equal to the inner surface of the peripheral wall upper surface 51C of the container body 5C, and the positions and lengths of the left and right vertical sides 135a and 135b of the fixing frame 131 are the left and right of the container body 5C. It is equal to the inner surface of the vertical peripheral walls 52aC and 52bC.
However, the remaining left and right inclined sides 136a and 136b and the lower side 137 of the frame portion 127 are smaller than the inner peripheral shape of the drug discharge portion 8C of the container body 5C. That is, the portion of the contact frame 132 of the frame portion 127 is smaller than the inner peripheral shape of the drug discharge portion 8C of the container body 5C.

A magnet 155 is attached to the contact frame 132. The magnet 155 functions as a stopper for maintaining the movable lid portion 134 in a closed state.
Further, the area of the frame portion 127 surrounded by the fixing frame 131 is bottomed and has a shielding wall 138.
A magnet 156 is provided on the shielding wall 138. The magnet 156 functions as a stopper for keeping the movable lid 134 open.
Further, bearing portions 140a and 140b are formed inside the left and right vertical sides 135a and 135b of the fixing frame 131.

Looking at the rear side of the lid main body 125, the inclined plate portion 141 extends diagonally downward from the back surface side of the shielding wall 138 of the frame portion 127. The tip end side (free end side) of the inclined plate portion 141 has a comb shape 142 as shown in FIG. Further, coil support walls 143a and 143b that hang downward are provided at positions near the free ends on both sides of the inclined plate portion 141.
A rectifying coil 126 is mounted between the two coil support walls as shown in FIG.
In the present embodiment, the rectifying portion 7C is composed of a comb-shaped 142 portion on the tip end side (free end side) of the inclined plate portion 141 and a rectifying coil 126 located below the comb-shaped portion 142.

As shown in FIGS. 13 and 14, the movable lid portion 134 is composed of a holding plate portion 145, a bearing portion 146, and a knob portion 147. The holding plate portion 145 is a substantially pentagonal plate. The shape of the holding plate portion 145 is equal to the opening shape of the lower region of the drug discharging portion 8C of the container body 5C.
The knob portion 147 projects from one side (upper side) of the holding plate portion 145. Further, a bearing portion 146 is formed between the knob portion 147 and the holding plate portion 145.

The movable lid portion 134 is attached to the frame portion 127 via the shaft 144 shown in FIG. That is, a common shaft 144 is inserted through the bearing portions 140a and 140b of the frame portion 127 and the bearing portion 146 of the movable lid portion 134, and the movable lid portion 134 is swingably attached to the frame portion 127. Further, the shaft 144 is provided with torsion coil springs 148a and 148b, and the holding plate portion 145 of the movable lid portion 134 is urged in a direction in contact with the contact frame 132 side of the frame portion 127.
In the state where the movable lid portion 134 is attached to the frame portion 127, the front shape of the lid main body portion 125 is equal to the opening shape of the drug discharge portion 8C of the container main body 5C.
An iron plate is provided on the back surface side of the movable lid portion 134 and corresponding to the magnets 155 and 156 described above.

The lid member 120 is attached to the drug discharge portion 8C of the container body 5C as shown in FIGS. 12 and 13. That is, the fixing frame 131 of the lid member 120 is attached to the drug discharging section 8C, and the upper half (based on the horizontal posture) of the opening portion of the drug discharging section 8C is closed by the shielding wall 138. On the other hand, since the contact frame 132 of the frame portion 127 is smaller than the opening portion of the drug discharge section 8C, there is a gap between the lower side 137 of the contact frame 132 and the peripheral wall lower surface 12C of the drug discharge section 8C. is there. That is, assuming a state in which the movable lid portion 134 is removed while the lid member 120 is attached to the container body 5C as shown in FIG. 17, the lower side 137 of the contact frame 132 and the lower surface 12C of the peripheral wall of the drug discharging portion 8C There is a gap 150 (drug discharge part) between them.
However, the holding plate portion 145 of the movable lid portion 134 is larger than the contact frame 132, and its shape is equal to the opening shape of the lower region of the drug discharging portion 8C of the container body 5C. The lower half of the portion (based on the horizontal posture) is also closed by the movable lid portion 134.

Therefore, when the movable lid portion 134 is closed, the entire surface of the drug discharging portion 8C is closed. An iron plate (not shown) is provided on the back surface of the movable lid portion 134, and the iron plate is attracted to the magnet 155 for maintaining the closed state provided in the contact frame 132. Therefore, the movable lid 134 maintains a closed posture.
On the other hand, when the movable lid portion 134 is opened by pressing the knob portion 147 of the movable lid portion 134, the gap 150 (drug discharge portion) is opened. An iron plate (not shown) is provided on the back surface of the knob portion 147, and the iron plate is attracted to the magnet 156 for maintaining the open state provided on the shielding wall 138 to maintain the open posture of the movable lid portion 134.

Also in this embodiment, the inside of the container body 5C is partitioned by the rectifying unit 7C, and the bottom surface 10C side with the rectifying unit 7C as a boundary functions as the powder storage unit 17. Further, the region on the side of the drug discharge portion 8C with the rectifying portion 7C of the lower surface 12C of the peripheral wall as a boundary functions as the lead-out path portion 18C. However, in the drug container 2C of the present embodiment, since the lid member 120 is provided with the rectifying section 7C, the length of the lead-out path portion 18C is shorter than that of the other drug containers 2A and 2B.

Next, the drug container 2D of the fourth form will be described with reference to FIGS. 34 to 41. The drug container 2D is an improvement of the above-mentioned third form of 2C, and although the design is different, the functions of the components are common in many respects. Therefore, the description of the drug container 2D of the fourth form will be limited to the points different from the 2C of the third form.

The drug container 2D is composed of a container body 5D, an iron plate portion 6D, and a lid member 120D.
The container body 5D is a vertically long container made of resin. The inner surface side of the lower surface 12D of the peripheral wall of the container body 5D is generally flat, but as shown in FIG. 39, there are inclined portions 181a and 181b at the back side portion. The inclined portion 181b on the back side is a gentle inclined surface, and the inclined portion 181a following it has a steep inclination. There is a recess 350 in the outer peripheral portion corresponding to the inclined portions 181a and 181b of the container body 5D.

As shown in FIG. 35, there is a step portion 160 near the opening of the container body 5D and outside the peripheral wall upper surface 51D, and there is a low ceiling portion 161 made to have a slightly lower height. An engaging member 162 is provided on the step portion 160. The engaging member 162 has a main body portion 166, engaging portions 163a and 163b, joining portions 164a and 164b, and a mounting portion 165. The main body portion 166 is a portion having a substantially quadrangular plate shape. Rod-shaped joints 164a and 164b are provided on one side of the main body 166. The joint portions 164a and 164b are arranged in the same plane as the main body portion 166. The joints 164a and 164b extend in parallel. Hook-shaped engaging portions 163a and 163b are provided on the side of the main body portion 166 opposite to the side on which the joint portions 164a and 164b are provided. The engaging portions 163a and 163b project in a direction orthogonal to the main body portion 166. Further, a mounting portion 165 is provided on the main body portion 166. The mounting portion 165 stands upright in the same direction as the engaging portions 163a and 163b, and is a table on which the push member 240 described later is mounted. The joint portions 164a and 164b are cantilevered to the step portion 160 of the container body 5D. That is, the engaging member 162 is connected to the step portion 160 of the container main body 5D via the joint portions 164a and 164b, and the main body portion 166 is arranged in parallel with the low ceiling portion 161. The engaging member 162 has elasticity.
A lid member 237 is attached to the low ceiling portion 161. The lid member 237 is provided with an upper surface opening 238 and a front surface opening 239.
A pushing member 240 is provided in the space 372 between the low ceiling portion 161 and the lid member 237. The lower surface of the pushing member 240 is in contact with the mounting portion 165, and the upper portion protrudes from the upper surface opening 238 of the lid member 237.
The transport iron plate portion 157D is divided into two small transport iron plate portions 157aD and 157bD.

The lid member 120D is composed of a lid main body portion 125D, a movable lid portion 134D, a rectifying coil 126D, and a comb-shaped rectifying member 130D. Further, a desiccant 182 is arranged on the lid member 120D as shown in FIG. 39 and the like.
The lid main body 125D is made by joining two lid main pieces 125a and b as shown in FIGS. 37 and 38. Hereinafter, a state in which the two are combined will be described as a reference.
The lid member 120D has a frame portion 127D on the front surface side and a coil support portion 128D on the rear surface side.

Further, the frame portion 127D on the front side has a portion that functions as a fixing frame 131D and a portion that functions as a contact frame 132D.
The area of the frame portion 127D surrounded by the fixing frame 131D is bottomed and has a shielding wall 138D.
The area surrounded by the fixing frame 131D is a recess 373 as shown in FIGS. 38 and 39. A leaf spring 185 is provided on the surface of the shielding wall 138D, which is a recess 373, as shown in FIGS. 39 and 40. The leaf spring 185 has mounting portions 186a and 186b at both ends as shown in FIG. 38. The region sandwiched between the two attachment portions 186a and 186b is the functional region 187, which is formed in a bent shape and has a corner portion 188.

Looking at the rear side of the lid body portion 125D, the inclined plate portion 141D extends diagonally downward from the back surface side of the shielding wall 138D of the frame portion 127D. However, the central portion of the inclined plate portion 141D has a large opening as shown in FIG. 37. Therefore, when the lid main body 125D is viewed from the rear side, there is a recess 190 as shown in FIG. 37. In the present embodiment, the comb-shaped rectifying member 130D is attached to the opening of the recess 190, and the recess 190 is closed by the comb-shaped rectifying member 130D.
The comb-shaped rectifying member 130D is a member in which a comb-shaped portion 365 is formed at the tip end portion of the plate-shaped portion 362. The plate-shaped portion 362 is provided with a plurality of small holes 366 for ensuring air permeability.
In the present embodiment, the comb-shaped rectifying member 130D has an engaging portion 191 on one side, and by engaging the engaging portion 191 inside the recess 190, the comb-shaped rectifying member 130D is placed on the rear side of the lid main body portion 125D. It is attached to.
In the present embodiment, since the comb-shaped rectifying member 130D is removable, the comb-shaped rectifying member 130D can be replaced according to the properties of the drug.
Further, a desiccant 182 is built in the recess 190. For the sake of drawing, the desiccant 182 is drawn as if a granular one was directly put in, but it is desirable to put it in the recess 190 in a state of being packed in a bag or the like.
In the present embodiment, the desiccant 182 is inserted into the recess 190, and the recess 190 is closed by the comb-shaped rectifying member 130D. However, since the comb-shaped rectifying member 130D is provided with the small hole 366, the drug container 2D The drug introduced into the container can be dehumidified.

Further, an engaging plate 192 extending in the horizontal direction is provided on the rear side of the lid main body portion 125D and in the vicinity of the upper portion thereof. The engaging plate 192 is provided with an engaging hole 193.
The movable lid portion 134D is composed of a pressing plate portion 145D, a shaft portion 194, and a knob portion 147D. The knob portion 147D is on an extension of the holding plate portion 145D, and the knob portion 147D forms the same plane as the holding plate portion 145D.
A pad 236 is provided on the back surface side of the pressing plate portion 145D.

The shaft portion 194 is provided on the left and right side portions of the holding plate portion 145D. The shaft portion 194 has an elastic portion 235 having a hairpin shape as observed from above as shown in FIG. 35. The elastic portion 235 has a forward side portion 195 extending rearward as shown in FIG. 35 with the side of the holding plate portion 145D as a base end, and a return side portion 196 that is folded back in a "U" shape and reaches the front side. It has elasticity as a whole. A shaft piece 197 is provided on the outside of the return side portion 196.

Further, an engaging piece 149 protrudes from the back surface side of the holding plate portion 145D. The engaging piece 149 has a rod shape or a plate shape, and is provided on the holding plate portion 145D in a cantilever shape. A recess 198 and a small protrusion 199 are provided at the tip of the engaging piece 149.

The movable lid portion 134D is attached to the lid main body portion 125D by engaging the shaft piece 197 of the shaft portion 194 with the bearing portions 140aD and 140bD of the lid main body portion 125D.
At the time of installation, the elastic portion 235 is bent to shorten the distance between the left and right shaft pieces 197, the back surface side of the movable lid portion 134D is inserted into the recess 373 of the lid body main portion 125D, and the elastic portion 235 is in that state. To engage the left and right shaft pieces 197 with the bearing portions 140aD and 140bD. When removing the movable lid portion 134D, on the contrary, the elastic portion 235 is bent to shorten the distance between the left and right shaft pieces 197, and the left and right shaft pieces 197 are separated from the bearing portions 140aD and 140bD.

The lid member 120D is attached to the drug discharge section 8D of the container body 5D as shown in FIG. 39. When the lid member 120D is attached to the container body 5D, the engaging plate 192 of the lid member 120D enters the internal space through the front opening 239 of the lid member 237 as shown in FIG. 40A, and the engaging plate 192 is engaged. The engaging portion 163 of the engaging member 162 is engaged with the joint hole 193.
When the pushing member 240 of the container body 5D is pushed down as shown in FIG. 40B, the engaging member 162 bends, and the engaging portion 163 of the engaging member 162 and the engaging hole 193 of the engaging plate 192 are engaged with each other. Can be solved. Therefore, the lid member 120D can be easily removed from the container member 5D.

In the present embodiment, when the movable lid portion 134D is closed, the recess 198 of the engaging piece 149 engages with the corner portion 188 of the leaf spring 185 as shown in FIG. 39A, and the movable lid portion 134D Stable in a closed position.
When opening the movable lid portion 134D, the knob portion 147D of the movable lid portion 134D is pressed. As a result, the movable lid portion 134D swings around the shaft piece 197 (FIG. 35). At this time, the recess 198 of the engaging piece 149 that was engaged with the corner portion 188 of the leaf spring 185 moves with the swing of the movable lid portion 134D, and the tip portion moves against the elastic force of the leaf spring 185. .. Then, as shown in FIG. 39B, the small protrusion 199 of the engaging piece 149 gets over the corner portion 188 of the leaf spring 185, and the movable lid portion 134D stabilizes in the open posture.

Next, the drug container 2E of the fifth form will be described with reference to FIGS. 43 and 44. The drug container 2E is provided with a large opening 300 at the upper surface 51D of the peripheral wall of the container body 5D of the fourth form described above, and a large lid 301 is provided at the opening 300. In the drug container 2E, the large lid 301 can be opened to charge the drug inside.
Further, the shape of the top surface when the large lid 301 is turned inside out is made to match the shape of the bottom surface of the container body 5E. Since the bottom surface side when the large lid 301 is turned upside down is larger than the top surface, the large lid 301 maintains a stable posture when the large lid 301 is turned over and placed on a desk.
Therefore, as shown in FIG. 44, by removing the large lid 301, turning it over, and laying it on the container body 5E, it can be used as a base for the container body 5E.
The container body 5F, which is still another embodiment, will be described later.

Next, the main body device 3 will be described.
As shown in FIGS. 19 to 25, the main body device 3 is composed of a vibrating table 20, vibration means 21a and 21b, an intermediate table 22, a vibration isolating table 23, a weight measuring means 25, and a foundation member 26 from the top.

The shaking table 20 is a block-shaped mounting table.
The external shape of the shaking table 20 is as shown in FIGS. 19 and 20, and is a substantially rectangular parallelepiped. That is, the shaking table 20 has a shape surrounded by a mounting surface 61 which is an upper surface, side surfaces 62a and b on the long side side, side surfaces 63a and 63b on the short side side, and a bottom surface 65.
An edge portion 66 (FIG. 21) is provided on the long side portion of the mounting surface 61 which is the upper surface. The surface of the edge 66 is inclined with respect to the mounting surface 61. That is, the edge 66 of the mounting surface 61 has an inclined surface 68. The angle formed by the mounting surface 61 and the inclined surface 68 is substantially equal to the angle formed by the peripheral wall lower surface contact portion 55 of the iron plate portion 6 and the inclined peripheral wall contact portions 56a and b.

The mounting surface 61 is provided with magnet mounting holes 28a, 28b and sensor mounting holes 73a, b, c, d.
The magnet mounting holes 28a and 28b are provided linearly side by side on the center line of the mounting surface 61. The sensor mounting holes 73a, b, c, and d are provided at the four corners of the mounting surface 61.

Inclined surfaces 67a and b are formed in the central portion of the short side side surfaces 63a and 63b of the shaking table 20.
The inclined surfaces 67a and b all cover substantially the entire height direction of the short side side surfaces 63a and 63b. Further, the two inclined surfaces 67a and b are parallel, and the quadrangle composed of the mounting surface 61, the two inclined surfaces 67a and b and the bottom surface 65 has a parallelogram as shown in FIGS. 24 and 25. .. More specifically, one inclined surface 67a has a notch on the mounting surface 61 side and is an uphill from the bottom surface 65 side to the mounting surface 61, whereas the other inclined surface 67b has a bottom surface. The inclination from the 65 side to the mounting surface 61 has an overhang shape.

Also in this embodiment, the electromagnets 30a and 30b are built in the magnet mounting holes 28a and 28b. Further, the electromagnets 30a and 30b are fixed to the bottoms of the magnet mounting holes 28a and 28b via elastic bodies 32a and b. Therefore, the electromagnets 30a and 30b have a slight degree of freedom with respect to the shaking table 20.
The suction portions (tips of the iron cores) 31a and 31b of the electromagnets 30a and 30b are located slightly lower than the mounting surface 61 which is the upper surface of the shaking table 20 as shown in FIG.
Contact sensors 33a, b, c, d are provided in the sensor mounting holes 73a, b, c, d. That is, in the present embodiment, contact sensors 33a, b, c, d are provided at the four corners of the mounting surface 61.

Further, a vibration detection sensor 35 is attached to the short side side surface 63b of the shaking table 20. That is, in the present embodiment, the sensor bracket 70 is attached to the shaking table 20, and the vibration detection sensor 35 is provided via the sensor bracket 70. In the present embodiment, the sensor bracket 70 is made by bending a steel plate into a substantially “C” shape, and as shown in FIG. 20, both sides of the rectangular sensor holding portion 69 and the sensor holding portion 69 are bent. It is composed of a space-holding plate 74 formed by being formed, and a mounting inner flange 79 formed by further bending the other end of the space-holding plate 74 inward. The mounting inner flange 79 is screwed to the short side side surface 63b of the shaking table 20 (screws are not shown).
In the present embodiment, the sensor bracket 70 functions not only as a function of holding the vibration detection sensor 35 but also as a fitting recess 108 for preventing the movement of the drug container 2 as described later. That is, in the present embodiment, there is a gap between the sensor holding portion 69 of the sensor bracket 70 and the short side side surface 63b of the shaking table 20, and this gap functions as the fitting recess 108.

The vibrating means 21a and 21b are piezoelectric elements, have a plate-shaped main body 71, and thin plate-shaped connecting pieces 72a and b are provided at both ends thereof. The connection pieces 72a and 72b are provided with two openings 64 for attaching screws.

Next, the intermediate table 22 will be described.
As shown in FIG. 20, the intermediate table 22 has a substantially "H" shape in a plan view.
That is, the intermediate base 22 has a rectangular main body portion 76 and four projecting portions 77a, b, c, d protruding from the four corners of the main body portion 76 along the long sides when viewed in a plan view.
The short sides of the main body 76 and the regions sandwiched between the protruding portions 77a, b, c, and d are inclined surfaces 78a, b.

The inclined surfaces 78a and b correspond to the inclined surfaces 67a and b of the shaking table 20 described above.
That is, the inclined surfaces 78a and b of the intermediate table 22 are parallel, and the inclination angle is the same as the inclined surfaces 67a and b of the shaking table 20.
Further, the inclined surface 67a of the shaking table 20 is on the extension of the inclined surface 78a of the intermediate table 22, and the inclined surface 67b of the shaking table 20 is on the extension of the inclined surface 78b of the intermediate table 22.

Looking inside the intermediate base 22, as shown in FIG. 22, there is a large cavity 75 inside the main body 76, and the back surface of the main body 76 is widely open.
Further, as shown in FIG. 23, a round hole 85 that opens downward is provided inside the four protrusions 77a, b, c, and d.

A weight 87 is attached to one of the short sides of the intermediate base 22 via a bracket 86 as shown in FIGS. 19 and 20. The weight 87 is a square columnar steel material.

Next, the vibration isolation table 23 will be described.
As shown in FIG. 20, the anti-vibration table 23 is a plate body having a central portion protruding and a space provided inside.
That is, the vibration isolator 23 has a shape in which one plate is bent, and a ridge 80 having a cross-sectional shape of "U" extends along the longitudinal direction in the center. That is, the ridge 80 has a top surface 81 and vertical walls 82a and b hanging from both sides of the top surface 81 when viewed from the inside.
Flange portions 88a and 88b are provided at the open end of the ridge 80 along both sides thereof. That is, the lower ends of the vertical walls 82a and b are bent outward from each other to form the flange portions 88a and b. The flange portions 88a and 88b are both elongated plates, and the length thereof is longer than that of the ridge 80. That is, both ends of the flange portions 88a and b are further outside the both ends in the longitudinal direction of the ridge 80.
The protruding portions at both ends of the flange portions 88a and b function as intermediate base support portions 83a, b, c and d.

The positional relationship of each part of the anti-vibration table 23 corresponds to that of the intermediate table 22 described above. That is, the ridge 80 provided in the center of the vibration isolation table 23 has a size and a positional relationship that fits in the cavity 75 of the intermediate table 22.
Further, the positions of the four intermediate base support portions 83a, b, c, d of the vibration isolation base 23 correspond to the four protrusions 77a, b, c, d of the intermediate base 22.

The foundation member 26 has a quadrangular flat plate portion 97, and the four corner portions thereof are cut up to form spring support portions 90a, b, c, d.

Next, the positional relationship of each component of the main body device 3 of the present embodiment will be described. In the main body device 3, as shown in FIGS. 19, 20, 24, and 25, the vibrating means 21a and 21b are provided between the shaking table 20 and the intermediate table 22.
In the present embodiment, the connecting plates 91a and 91b are interposed between the vibrating table 20 and the vibrating means 21a and 21b, and the connecting pieces 72a and the vibrating table of the vibrating means 21a and 21b are interposed via the connecting plates 91a and 91b. 20 is attached.
On the other hand, the intermediate base 22 and the vibrating means 21a and 21b are directly connected.
In the present embodiment, both the shaking table 20 and the intermediate table 22 have inclined surfaces 67a and b and inclined surfaces 78a and b, and the vibrating means 21a and 21b have the inclined surfaces 67a and b and the inclined surfaces 78a and b of both. It is attached to.

More specifically, the connecting pieces 72a on the upper side of the vibrating means 21a and 21b and the connecting plates 91a and 91b are sandwiched between the two pressing blocks 93a and b, and the screw 99a is inserted between them. The vibrating means 21a and 21b and the connecting plates 91a and 91b are fixed.
Further, the connection plates 91a and 91b are in contact with the inclined surfaces 67a and b of the shaking table 20, and are attached to the inclined surfaces 67a and b of the shaking table 20 by the pressing block 93c and the screw 99b.

On the other hand, on the lower side of the vibrating means 21a and 21b, the connecting piece 72b is brought into contact with the inclined surfaces 78a and b of the intermediate base 22, and is attached to the inclined surfaces 78a and b of the intermediate base 22 by the pressing block 93d and the screw 99c. Has been done.

In the present embodiment, the vibrating means 21a and 21b exist between the shaking table 20 and the intermediate table 22, and the shaking table 20 is not supported at a portion other than the vibrating means 21a and 21b. Therefore, the vibrating table 20 has a structure in which the vibrating table 20 is hollowly supported from the intermediate table 22 by the vibrating means 21a and 21b.

A vibration isolation table 23 is arranged below the intermediate table 22. Explaining the positional relationship between the two, as shown in FIGS. 22, 23, 24, the ridge 80 provided in the center of the vibration isolation table 23 has entered the cavity 75 of the intermediate table 22. However, the top surface 81 of the ridge 80 and the inner surface of the cavity 75 of the intermediate base 22 are not in contact with each other. That is, although the intermediate table 22 and the vibration isolation table 23 are intricate, they are mechanically the same as the structure shown in FIG. 1, and the top surface 81 of the ridge 80 and the inner surface of the cavity 75 of the intermediate table 22 are in contact with each other. Not.

Further, there are intermediate base support portions 83a, b, c, d of the vibration isolation table 23 directly below the four protrusions 77a, b, c, d of the intermediate base 22, and the two are connected by a vibration isolation member 40. ing.
The vibration-damping member 40 is a member having both a vibration-damping function and a vibration-damping function, and is a combination of a spring 38 and a vibration-damping rubber 96 as shown in the figure.
That is, the four protrusions 77a, b, c, and d of the intermediate base 22 are provided with round holes 85 that open downward as shown in FIG. 23, and most of the springs 38 are provided in the intermediate base 22. It has entered the round hole 85.
In the present embodiment, there is no member other than the vibration-proof member 40 described above that connects between the intermediate table 22 and the vibration-proof table 23. Therefore, the intermediate base 22 has a structure in which the intermediate base 22 is hollowly supported from the vibration isolation base 23 by the vibration isolation member 40.
As described above, although the intermediate base 22 and the vibration isolation table 23 are intricate, the structure is mechanically the same as that shown in FIG. 1, and the intermediate base 22 is hollowed out from the vibration isolation table 23 by the vibration isolation member 40. It has a supported structure.

Further, a weight measuring means 25 is arranged below the vibration isolator 23 as shown in FIGS. 22, 23, 24, and a foundation member 26 is further arranged below the weight measuring means 25.
Most of the weight measuring means 25 is located in the ridge 80 provided in the center of the vibration isolator 23 as shown in FIGS. 22, 24, 25, and the upper installation surface 36 of the weight measuring means 25 is vibration-proof. It is connected to the inner surface of the top surface 81 of the ridge 80 of the base 23.
On the other hand, the lower installation surface 37 of the weight measuring means 25 is attached to the foundation member 26.
As described above, since the upper installation surface 36 and the lower installation surface 37 are at offset positions, the intermediate portion of the weight measuring means 25 has a structure that is cantilevered with respect to the foundation member 26. The vibration isolator 23 is supported on the free end side.
In the present embodiment, most of the weight measuring means 25 is embedded in the anti-vibration table 23 and the intermediate table 22, and although they have a complicated positional relationship, they are mechanically the same as the structure shown in FIG. The intermediate portion of the weight measuring means 25 has a structure that is cantilevered with respect to the base member 26, and the vibration isolator 23 is supported on the free end side thereof.

In the present embodiment, there is no member other than the weight measuring means 25 described above that connects the vibration isolator 23 and the foundation member 26. Therefore, the vibration isolator 23 has a structure that is hollowly supported from the foundation member 26 by the weight measuring means 25.
Further, in the present embodiment, most of the weight measuring means 25 is located in the ridge 80 provided in the center of the vibration isolator 23 as shown in FIGS. 24 and 25, and is in the center of the vibration isolator 23. Since the ridge 80 provided in the intermediate table 22 is located in the hollow portion 75 of the intermediate table 22, it can be said that most of the weight measuring means 25 is embedded in the intermediate table 22 in the height direction.
Therefore, in the present embodiment, the height of the weight measuring means 25 has a small influence on the total height of the main body device 3, and the total height of the main body device 3 is low.

Further, the foundation member 26 is attached to the vicinity of the distribution plate 212 of the powder distribution device 202 via the vibration isolation member 41 as in the previous embodiment.
That is, the four corners of the foundation member 26 are cut up to form the spring support portions 90a, b, c, d (FIG. 19), and the lower surfaces of the spring support portions 90a, b, c, d and the powder are powdered. The base of the packaging device 202 and the like are attached via the vibration isolator 41. The anti-vibration member 41 is composed of a spring 84 (FIG. 20) and an anti-vibration rubber (not shown).

Next, the function of the drug feeder 50 of the present embodiment will be described.
The function of the drug feeder 50 is almost the same as that of the drug feeder 1 described above, and the electromagnets 30a and 30b built in the shaking table 20 are energized to fix the drug containers 2A, 2B, 2C, 2D and 2E to the shaking table 20. Then, the drug containers 2A, 2B, 2C, 2D, and 2E are vibrated to discharge the powder. Hereinafter, a case where the drug container 2C (FIG. 12) is used will be described as an example. That is, a case where a drug container 2C of a type having a lid as a third form is used will be described as an example.
Also in this embodiment, the drug container 2C is fixed to the shaking table 20 by the magnetic force of the electromagnets 30a and 30b. Here, the drug container 2C has a step portion 121 on the drug discharge portion 8 side as shown in FIG. 11, and the peripheral wall lower surface 12C is divided into an upper step portion 123 and a lower step portion 122 with the step portion 121 as a boundary. The iron plate portion 6C is adhered to a portion on the outer peripheral surface side of the container body 5C and corresponding to the upper portion 123 of the peripheral wall lower surface 12C.
Therefore, in the present embodiment, as shown in FIG. 11, the upper portion 123 of the peripheral wall lower surface 12C of the container body 5C in the drug container 2C is fixed to the shaking table 20 by the magnetic force of the electromagnets 30a and 30b (FIG. 2).
Further, since the shape of the drug container 2C and the shape of the shaking table 20 are different from those of the previous embodiment, the drug container 2C behaves peculiarly.

That is, also in this embodiment, the drug container 2C is transported by the hand of the robot (not shown) or the like.
When being transported, the drug container 2C is changed from the initial vertical posture to the horizontal posture as shown in FIGS. 11 and 26 (a), and approaches the main body device 3.
At this time, the robot 43 of FIG. 1 controls the posture of the hand 45 so that the axis BC of the drug container 2C and the axis MC of the main body device 3 match as much as possible, but it is difficult to always completely match them. Therefore, as shown in FIG. 26 (b), the two may be misaligned.

Then, the drug container 2C is installed on the shaking table 20 in a state where the axis BC of the drug container 2C and the axis MC of the main body device 3 are displaced. In the present embodiment, the iron plate provided near the bottom of the drug container 2C is installed. The portion 6C has inclined peripheral wall contact portions 56aC and 56bC, and has a substantially tapered shape.
On the other hand, the shaking table 20 is also provided with an edge 66 on the mounting surface 61 as described above, and has a substantially tapered shape.
Therefore, when the drug container 2C is installed on the shaking table 20, it is guided by the taper, and the inclined peripheral wall contact portions 56aC and 56bC on the drug container 2C side coincide with the inclined surface 68 of the shaking table 20 as shown in FIG. It tends to be.

In addition, in the present embodiment, the protrusion 16C is provided near the rear end of the drug container 2C. On the other hand, in the drug feeder 50 of the present embodiment, there is a fitting recess 108 between the sensor holding portion 69 of the sensor bracket 70 and the short side side surface 63b of the shaking table 20. Therefore, in the present embodiment, when the drug container 2C is installed on the shaking table 20, the protrusion 16C of the drug container 2C fits with the fitting recess 108 on the main body device 3 side.

Therefore, the posture of the drug container 2C is corrected, and the axis BC of the drug container 2C and the axis MC of the main body device 3 come closer to each other as shown in FIG. 27 (b). However, the inclined peripheral wall contact portions 56aC and 56bC of the drug container 2C and the inclined surface 68 of the shaking table 20 do not completely match, and as shown in FIG. 27 (a), the inclined peripheral wall contact portions 56aC of the drug container 2C, In some cases, a portion D where 56bC and the inclined surface 68 of the shaking table 20 do not match may be formed. In this case, as shown in FIG. 27 (b), the axis BC of the drug container 2C and the axis MC of the main body device 3 are slightly deviated from each other.

When the electromagnets 30a and b are energized in this state, the flat peripheral wall lower surface contact portion 55C provided on the peripheral wall lower surface 12C of the drug container 2C is attracted to the electromagnets 30a and b, and the peripheral wall lower surface contact portion 55C vibrates. It is attracted to the table 20 side, and the peripheral wall lower surface contact portion 55C is brought into close contact with the mounting surface 61 of the shaking table 20. Then, the tapered shapes of the drug container 2C and the shaking table 20 match due to the force received at that time, and the axis BC of the drug container 2C and the axis MC of the main body device 3 match as shown in FIG. 28 (b).

Further, since the peripheral wall lower surface contact portion 55C of the drug container 2C is in close contact with the mounting surface 61 of the shaking table 20, the horizontal posture of the drug container 2C is also ensured.

In the present embodiment, the degree of adhesion between the drug container 2C and the shaking table 20 and the posture of the drug container 2C are provided on the condition that the contact sensors 33a, b, c, d provided at the four corners of the mounting surface 61 are electrically connected to each other. Is judged to be normal.

Also in the drug feeder 50 of the present embodiment, after the drug container 2C is fixed to the shaking table 20, the drug container 2C is vibrated to discharge the powder, and at this time, the drug container 2C also receives a force in the forward direction due to the vibration. However, in the drug feeder 50 of the present embodiment, since the protrusion 16C of the drug container 2C provided at the rear end of the drug container 2C is fitted with the fitting recess 108 on the main body device 3 side, the drug container 2C itself. Does not move in the axial direction.

Further, in the present embodiment, when the drug in the drug container 2C advances toward the drug discharge portion 8C, the drug passes through the comb-shaped 142 portion of the inclined plate portion 141 shown in FIG. 16 and the rectifying coil 126. It crosses the rectifying coil 126 and passes through the gap between the lines. Therefore, the flow of the drug is smoothed. Further, even if a lump of the drug is present, the lump collapses when passing through the comb-shaped portion 142 and the rectifying coil 126, and returns to the powder shape.

The operation of the drug feeder 50 has been described above by taking the case of using the drug container 2C of the third form as an example, but the same operation is performed even when the drug container 2D of the fourth form is used.
However, when the fourth form of the drug container 2D (FIG. 34) is used instead of the third form of the drug container 2C, there is an effect that the drug previously filled in the drug container 2D is preferentially discharged.
In the drug container 2D of the fourth form, since the lid member 120D is removed and the drug is filled inside, the drug is charged in a vertical posture. Therefore, the charged drug is deposited from the bottom surface 10D side of the container body 5D.
On the other hand, when discharging the drug, the drug container 2D is laid down in a horizontal position as shown in FIG. 42. Here, in the drug container 2D of the fourth form, there are inclined portions 181a and 181b on the inner surface side of the lower surface 12D of the peripheral wall and on the inner surface side. Therefore, as shown in FIG. 42, the old drug layer 360, which was previously charged into the drug container 2D and accumulated on the bottom surface 10D side of the container body 5D, wraps around under the new drug layer 361. Therefore, the drug in the old drug layer 360 is mixed with the drug in the new drug layer 361 and discharged.

Further, as the drug moves by vibration, the drug in the old drug layer 360 flows under the new drug layer 361.
Here, when the two layers of the chemicals move together and reach the position of the comb-shaped rectifying member 130D, the upper side of the two layers is scraped up by the plate-shaped portion 362 of the comb-shaped rectifying member 130D as shown in FIG. 42. Be done. In particular, since the comb-shaped rectifying member 130D is in an inclined posture as a whole, the upper side of the two layers is plowed up at the plate-shaped portion 362 of the comb-shaped rectifying member 130D, and further returned to the bottom surface 10D side as shown by an arrow. .. Therefore, the old drug layer 360 that moves on the lower layer side is preferentially discharged, and the flow of drug first-in first-out in the drug container 2D can be realized.

Next, the peripheral device of the drug feeder 50 will be described.
The drug feeder 50 of the present embodiment constitutes a part of the drug dispensing device 100 having a powdered powder packaging function.
The overall structure of the drug dispensing device 100 is as shown in FIG. 30, for example. The drug dispensing device 100 is functionally divided into a drug shelf region 103, a drug dividing region 105, and a drug packaging region 106 in the vertical direction.
A drug container storage shelf 101 is arranged around the uppermost drug shelf region 103, and a drug container moving device 102 is provided inside the drug container storage shelf 101.
The drug shelf region 103 is dehumidified by a dehumidifying device (not shown). Further, a dust collector (not shown) is provided inside the medicine shelf area 103, and dust in the medicine shelf area 103 is removed. For example, a blower fan is provided in the medicine shelf area 103, and the air in the medicine shelf area 103 is circulated by the blower fan. Then, a filter is provided in a certain ventilation path such as the intake side of the blower fan to remove dust and the like floating in the medicine shelf region 103.

The drug container moving device 102 includes a vertical elevating shaft 110, a horizontal moving arm 180, and a hand portion 112 that holds the drug container 2C. The horizontal movement arm 180 has joints 168 and 169 at two positions as shown in FIG. The hand portion 112 can change the posture of the drug container 2C. The drug container moving device 102 employs the hand portion 112 of the electromagnet 170. That is, as shown in FIGS. 30 and 31, an electromagnet 170 is provided at the tip of the horizontal moving arm 180.

A powder distribution device 202 is provided in the drug division region 105. In the present embodiment, the powder distribution device 202 has two distribution plates 212. A plurality of drug feeders 50 of the present embodiment are installed in the powder distribution device 202. In the present embodiment, a plurality of drug feeders 50 are installed on each distribution dish 212. More specifically, three drug feeders 50 are installed in each distribution dish 212. Each drug feeder 50 is attached tangentially to each distribution dish 212. The mounting angle of the drug feeder 50 with respect to each distribution dish 212 is not limited to the tangential direction, but by mounting the drug feeder 50 in the tangential direction with respect to each distribution dish 212, the drug distribution accuracy can be improved. It has an increasing effect. Further, when the drug container 2C is held by the drug container moving device 102 and the drug container 2C is fixed to the shaking table 20, or when the drug container 2C is removed from the shaking table 20, there is less unnecessary operation of the drug container moving device 102. The effect of becoming can be expected.
The drug packaging device 203 is built in the drug packaging area 106.
Further, the drug dispensing device 100 includes a prescription reading means 46 for reading a prescription and a control device 47 for controlling the operation of each device.

Further, on the outer wall side of the drug packaging area 106, a drug container inlet 151 as shown in FIG. 29 is provided. Inside the drug container inlet 151, a weight measuring means 152 such as a load cell and a reading device (not shown) are provided. As the reading device, a barcode reader, an RFID (Radio Frequency Identification) reader, or the like can be adopted.
When the drug container 2C is set in the drug container inlet 151, the total weight of the drug container 2C is measured internally and stored in the memory of the control device 47. Further, a bar code or the like (not shown) provided on the drug container 2C is read by a bar code reader or the like, and the drug container 2C is conveyed and stored at a predetermined position in the drug shelf region 103 by the drug container moving device 102.
Here, in the present embodiment, the drug container moving device 102 has a hand portion 112 of the electromagnet 170. In the present embodiment, as shown in FIG. 31, the electromagnet 170 is brought close to the transport iron plate portion 157 of the drug container 2C, and then the electromagnet 170 is energized to attract the transport iron plate portion 157 to hold the drug container 2C. Move.

It should be noted that a drug container of the second form, such as the drug container 2B (FIG. 9), which is a two-sided open type container and has a large open portion corresponding to the top surface when the container is in a horizontal position without a lid. When the container 2B is used, the drug that has been separately weighed or unweighed on a dispensing table or the like is charged from the open upper side of the drug container 2B (the upper side when the drug container 2B is in a horizontal position), and then the drug container is used. Set in the slot 151. When the drug container 2B of the second form is set, the total weight of the drug container 2B is measured, stored in the memory of the control device 47, and then directly transported to one of the drug feeders 50 by the drug container moving device 102. Then, an amount of the drug based on the prescription information is dispensed to the powder distribution device 202.

The control of the entire drug dispensing device 100 is generally as shown in the flowchart of FIG. 32.
Hereinafter, the operation of the entire drug dispensing device 100 will be described with reference to the flowchart of FIG. 32.

In the present embodiment, as shown in FIG. 32, all the operations are started by reading the contents of the prescription by the prescription reading means 46.
That is, when the contents of the prescription are input in step 1, the process proceeds to step 2, and the work of carrying out the drug container 2C is immediately started. More specifically, the drug container moving device 102 is driven, and the drug container 2 containing the drug matching the prescription is selected from a large number of drug containers 2 arranged in the drug shelf region 103, and the drug is selected. It is installed in the main body device 3 of the feeder 50. At this time, the grip portion 147 of the movable lid portion 134 is pressed by a pressing piece (not shown) to open the movable lid portion 134, and the movable lid portion 134 is opened by the attractive force of the magnet 156 for maintaining the open state. The state is maintained.

Then, the process proceeds to step 3, and the electromagnets 30a and 30b are energized to fix the drug container 2C to the shaking table 20.
After that, the process proceeds to step 4 and the timer is started to be timed. This timer defines the time for determining whether or not the drug container 2C is normally installed, and is as short as, for example, about 1 second.
If it is confirmed that all of the contact sensors 33a, b, c, and d are energized by the time the timer finishes timing (YES in step 5), it is determined that the drug container 2C has been installed in the normal posture, and the step Move to 6. On the other hand, if the contact sensors 33a, b, c, d cannot confirm the contact even after waiting for a certain period of time (step 12), there is a high possibility that there is a foreign substance on the shaking table 20 or the like. , Step 13 is performed and a series of operations are retried. More specifically, the energization of the electromagnets 30a and 30b is stopped, the drug container moving device 102 is driven, the drug container 2C is re-grasped and lifted by the hand portion 112, and the drug container 2C is lifted again by the main body device 3 of the drug feeder 50. And retry the operation after step 3.

When the energization in step 5 is confirmed by the first trial or the second trial and the process proceeds to step 6, the weight measurement of the drug container 2C is started. That is, the original weight G of the drug container 2C is measured and stored, and the current weight g of the drug container 2C is monitored.

Then, the process proceeds to step 7, and the vibration table 20 is started to vibrate, and the distribution plate 212 of the powder distribution device 202 is rotated.

Then, the process proceeds to step 8 to start timing the timer. In the following step 9, while monitoring the weight change of the drug container 2C per fixed time, in step 10, the predetermined amount of powder is waited to be dispensed.
That is, the weight change of the drug container 2C is monitored, and in step 9, it is confirmed that the weight is reduced by at least a certain amount or more per fixed time. If the weight has been reduced by at least a certain amount for a certain period of time, the medicine has fallen normally from the medicine container 2C, so the process proceeds to step 10, and whether or not a predetermined amount of powder has been dispensed in step 10. To confirm. If the amount of powdered medicine to be paid out is insufficient, the process returns to step 9. In this way, while confirming that the drug has fallen in steps 9 and 10, the predetermined amount of powdered drug is waited to be discharged.
That is, in step 10, the difference between the original weight G of the drug container 2C and the current weight g becomes a desired payout amount. Then, when the desired payout amount is reached, the process proceeds to step 11 to stop the vibration of the shaking table 20.

The subsequent steps are the same as those of the known drug dispensing device 100, in which the drugs are divided, scraped out, and individually packaged.

Further, if the weight reduction of the drug container 2C is stopped before the desired payout amount is reached, it is expected that the powder powder in the drug container 2C is insufficient because the continuous drop of the powder cannot be confirmed. Then, the process proceeds to step 14, an error display indicating that the powder is insufficient is displayed, and a series of steps is completed.

When the series of discharging steps and packaging steps are completed, the energization of the electromagnet is stopped, and the drug container moving device 102 is operated to return the drug container 2C to its original position.
Here, as a peculiar configuration of the drug dispensing device 100 of the present embodiment, when the drug container moving device 102 is operated to return the drug container 2C to the original position, the total weight of the drug container 2C is reweighed. More specifically, when returning the drug container 2C to its original position, the drug container 2C is once carried to the drug container inlet 151, and the drug container 2C is placed on the weight measuring means 152 provided in the drug container inlet 151. The total weight of the drug container 2C is reweighed.

Then, the total weight of the drug container 2C at the beginning (immediately before the current drug discharge) is compared with the total weight of the drug container 2C after the drug is discharged. Then, it is confirmed that the difference between the two matches the amount of the drug discharged during the above-mentioned process. That is, the process of confirming the amount of emissions is carried out.
Alternatively, the weight of the drug container 2C by the weight measuring means 152 provided in the drug container inlet 151 and the weight of the drug container 2C after discharging the drug measured by the drug feeder 50 are compared, and it is confirmed that they match. Confirm. That is, the verification step of whether or not the weight measuring means 25 of the drug feeder 50 is accurate is carried out.
Then, as a result of reweighing the total weight of the drug container 2C, if the total weight of the drug container 2C is normal, the drug container moving device 102 is operated to return the drug container 2C to the original position. If there is an abnormality in the total weight of the drug container 2C, an alarm is immediately issued to notify the pharmacist.

Next, a method of using the two-sided open type drug container 2B of the second form and the drug container 2E of the fifth form will be described.
The drug containers 2B and 2E of the second and fifth forms are used when manually packaging powders and the like. That is, there are drugs that are rarely used, drugs that are highly toxic, and drugs that are not suitable for storage in the drug container storage shelf 101 of the drug dispensing device 100 because of their high hygroscopicity and weakness to high temperatures. Alternatively, it may be necessary to crush the tablets or capsules before prescribing.
In such a case, the second and fifth forms of the drug containers 2B and 2E are fixed to the shaking table 20 of the drug feeder 50, and a rough amount of the drug is charged into the drug containers 2B and 2E from the opened upper side. To do. When the drug container 2E of the fifth form is used, the large lid 301 is removed, the opening 300 is opened, and the drug is charged through the opening 300. After that, the weight of the drug container 2B is measured. That is, the original weight G of the drug containers 2B and 2E is measured and stored, and the current weight g of the drug containers 2B and 2E is monitored.
After that, the vibration table 20 is started to vibrate, and the distribution plate 212 of the powder distribution device 202 is rotated so that the difference between the original weight G of the drug containers 2B and 2E and the current weight g becomes the desired payout amount. wait. Then, when the desired payout amount is reached, the vibration of the shaking table 20 is stopped.

In the embodiment described above, the drug feeders 1 and 50 are used to supply the powder to the distribution dish 212 of the powder distribution device 202, but the drug feeders 1 and 50 may directly supply the powder to the drug packaging device 203. Good.
It is also conceivable to supply tablets and capsules using the drug feeders 1, 50 of the present invention.

In the embodiment described above, in the drug feeders 1 and 50, contact sensors 33a, b, c, and d are provided at the four corners of the shaking table 20, but the number of contact sensors is arbitrary. However, in order to determine whether or not the shaking table 20 is in close contact with the bottoms of the drug containers 2A, 2B, 2C, 2D, 2E, at least two or more contact sensors are provided in the longitudinal direction of the shaking table 20. It is desirable that it is. Further, in order to confirm that the axes of the drug containers 2A, 2B, 2C, 2D, and 2E coincide with the axes of the shaking table 20, at least two or more contact sensors in the width direction of the shaking table 20 are used. It is desirable that

In the embodiment described above, the weight of the drug container 2C immediately after installation on the shaking table 20 is stored as the original weight G, the current weight of the drug container 2C is the current weight g, and the difference between the two is the amount of powdered powder discharged. However, the amount of powdered powder discharged may be obtained from the total detected weight of the weight measuring means 25. That is, the weight including the weight of the device such as the shaking table 20, and the weight detected by the weight measuring means 25 immediately after the drug containers 2A, 2B, 2C, 2D, and 2E are installed on the shaking table 20, is taken as the original weight G, and the powder is powdered. The detected weight of the weight measuring means 25 during discharge may be the current weight g, and the difference between the two may be the discharge amount of the powder.

In the embodiment described above, the electromagnets 30a and 30b are adopted as the container holding means, and the configuration in which the drug container 2 is directly adsorbed by the electromagnets 30a and 30b is adopted. That is, in the embodiment described above, the container holding means using magnetic force is adopted.
However, the present invention is not limited to this configuration, and the drug container 2 may be held by other mechanical means. For example, a configuration in which some engaging member or fitting member is operated by a solenoid, a small motor, an air cylinder, or the like to mechanically hold the drug container 2 can be adopted.

Further, in the above-described embodiment, the electromagnets 30a and 30b are energized to fix the drug container 2 to the shaking table 20, but the drug container 2 is mounted on the shaking table by using a permanent magnet or by using a permanent magnet and an electromagnet in combination. It may be fixed to 20.
Specifically, instead of the electromagnets 30a and 30b, a non-excited electromagnet or a magnet having a structure called a self-holding solenoid is adopted as the container holding means.
The above-mentioned self-holding solenoid or the like is a combination of a permanent magnet and an electromagnet, and always exerts an attractive force mainly by the permanent magnet. Then, when the magnetized object is separated from the self-holding solenoid or the like, the electromagnet is energized to generate a magnetic force in the direction opposite to that of the permanent magnet.
Alternatively, the electromagnet is energized during attraction to generate a magnetic force in the same direction as the permanent magnet, and at the time of detachment, a current in the opposite direction is passed to generate a magnetic force in the direction opposite to that of the permanent magnet.

Since the shapes of the electromagnets 30a and 30b and the self-holding solenoid are similar, the shape of the main body device 3 is the same as that of FIGS. 19 to 25 described above even when the self-holding solenoid is adopted. With reference to FIGS. 19 to 25 and 32, the container holding means will be described as the self-holding solenoids 30a and 30b.
When the self-holding solenoids 30a and 30b are used, the self-holding solenoids 30a and 30b are energized to suppress the generation of magnetic force when the work of carrying out the drug container 2 is started in step 2 described above.
Then, as in the previous embodiment, the work of carrying out the drug container 2 is started. A drug container 2C containing a drug matching the prescription is selected from a large number of drug containers 2 and installed in the main device 3 of the drug feeder 50.

Then, the energization of the self-holding solenoids 30a and 30b is stopped, and the magnetic force of the permanent magnet is exerted to fix the drug container 2 to the shaking table 20.
The following steps are the same as those in the above-described embodiment, but when the drug container 2 is separated from the shaking table 20, the self-holding solenoids 30a and 30b are energized again to cancel the magnetic force of the permanent magnet.
Since the self-holding solenoids 30a and 30b maintain the attractive force in a non-energized state, the power consumption is smaller than that in the configuration using the electromagnets 30a and 30b. In that respect, the configuration using the self-holding solenoids 30a and 30b is superior to the configuration using the electromagnets 30a and 30b.
Further, the self-holding solenoids 30a and 30b consume less power and generate less heat. Therefore, it is also recommended because it has a small effect on the drug in the drug container 2.

In the embodiment described above, the protrusion 16C is provided on the drug container 2C side to engage with the main body device 3 side to prevent the drug container 2C from advancing. However, the protrusion is provided on the main body device 3 side to prevent the drug container 2C from advancing. , 2B, 2C, 2D, 2E side is partially engaged, or a recess is provided in the drug container 2.

In the above-described embodiment, as the vibration-damping members 40 and 41, a combination of a spring and a vibration-damping rubber is illustrated, but a vibration-damping member using a single spring may be adopted, and the vibration-damping members are made of only resin or the like. A vibration-proof member may be adopted.

In the embodiment described above, the vibration isolator 40 is provided between the intermediate table 22 and the vibration isolation table 23 to prevent vibration from being transmitted to the vibration isolation table 23, but in addition to this configuration or this configuration. Instead, it is also recommended to remove the effects of vibration by software. For example, a method of Fourier transforming the detected value of the weight measuring means 25 to remove the influence of vibration can be considered.

In the embodiment described above, the total weight of the drug container 2C is reweighed using the weight measuring means 152 provided in the drug container inlet 151, but the weight measuring means is provided in another portion of the drug container 2C. The total weight may be reweighed. Further, the drug container 2C may be remounted from the drug feeder 1,50 used for discharging the drug to another drug feeder 1,50, and the total weight may be reweighed. That is, by reweighing, if it is found that there is some abnormality in the measured value, it also leads to detection of a failure of any of the compared weight measuring means 25 and 152.
Further, the step of reweighing is not essential and may be omitted.

In the embodiment described above, a configuration is adopted in which the vibration of the shaking table 20 is stopped after the difference between the original weight G of the drug container 2C and the current weight g reaches the desired payout amount, but in consideration of the time lag. It is also recommended to stop the vibration of the shaking table 20 in a state where the difference between the original weight G and the current weight g is slightly smaller than the desired payout amount.

Further, in the embodiment described above, the weight of the drug container 2C is monitored to decrease, and it is confirmed that the drug continues to fall. However, a powder drop sensor is separately provided and the powder drop sensor is used. You may want to make sure that the drug continues to fall.

In the embodiment described above, as the container moving means, one having a hand 45 (FIG. 1) of a type that grips the drug container 2 and one having a hand portion 112 (FIG. 30) using an electromagnet are adopted. In the former hand 45, the hand 45 itself operates independently of the arm. In the latter hand portion 112, the hand portion 112 itself is integrated with the arm and does not operate relative to each other, and holds the drug container 2 by physical adsorption.
Alternatively, a hand holding the drug container 2 by physical fitting or engagement can be considered.
For example, as in the combination of the drug container 2F shown in FIG. 33 and the hand 172, they are engaged by moving each other relative to each other.
That is, as shown in FIG. 33, the drug container 2F is provided with a guide rail 173 on the upper surface 51D of the peripheral wall. The guide rail 173 has engaging grooves 174 on both sides.
One hand 172 is provided with a groove 175 having a "C" cross-sectional shape. The tip side of the groove 175 in the longitudinal direction is open as shown in the figure. Further, the rear end of the groove 175 in the longitudinal direction is closed (not shown).
The cross-sectional shape of the groove 175 of the hand 172 is similar to the cross-sectional shape of the guide rail 173, and both can be engaged with each other. You can't.
The hand 172 is integrally attached to the robot arm.

When the drug container 2F is held by the hand 172 shown in FIG. 33, the robot arm is operated to bring the hand 172 closer to the drug container 2F, and the end of the guide rail 173 is aligned with the open end of the groove 175. Then, the robot arm is linearly moved to insert the guide rail 173 into the groove 175. As a result, the drug container 2F has a degree of freedom only in the direction along the guide rail 173, and is substantially held by the hand 172.

Further, the main body device 3 has members for energizing such as electromagnets 30a and 30b, self-holding solenoids 30a and 30b, and vibration means (piezoelectric element), and easily generates heat. When there is a concern that heat generation may affect the drug in the drug container 2, it is desirable to provide a cooling means for cooling the main body device 3.
As an example of the cooling means, it is conceivable that the main body device 3 is provided with the cooling fins 305 or the blower 306 is provided in the vicinity as shown in FIG.

Further, as a more developed configuration, a configuration in which the vibration pattern of the shaking table 20 can be changed according to the drug type, the discharge timing, and the total discharge amount is recommended.
Drugs have different particle sizes and hygroscopicity depending on the type. Therefore, when the shaking table 20 is vibrated, the behavior of the drug in the drug container 2 differs depending on the drug.
There are chemicals that rectify and flow easily when subjected to vibration, and chemicals that are difficult to rectify. The amount of movement in one vibration differs depending on the type of drug.
In addition, there is a problem that the amount of drug discharged is not stable at the initial stage of drug discharge.

Therefore, the frequency (frequency) per unit time and the magnitude of the amplitude can be changed, and the magnitude of the frequency and the amplitude can be changed according to the drug type, the discharge time, and the total discharge amount.
For example, the ease of excretion of a drug is tested in advance, and all the drugs scheduled to be excreted are classified into a plurality of stages by the drug feeders 1 and 50. This is referred to as, for example, a “flow coefficient”, and the drug is classified into a flow coefficient 1 to a flow coefficient 3.
In addition, the emission level is divided into multiple stages according to the total emission of the drug. For example, the emission amount is divided into 20 grams, and is referred to as "emission amount 20, emission amount 40, emission amount 60".
In addition, the vibration level is divided into a plurality of stages according to the frequency and amplitude of the vibration. This is referred to as, for example, "vibration level 1, vibration level 2", and it is assumed that the vibration level can be changed from, for example, vibration level 1 (minimum vibration) to vibration level 20 (maximum vibration).

Then, an appropriate vibration level is selected according to the "flow coefficient" and the "emission amount". The vibration level distinguishes between the vibration level at the initial stage of discharge and the vibration level at the stable period.
For example, if the drug is easily discharged such as "flow coefficient 1" and the total discharge amount is small such as "discharge amount 20", vibration is started with slow vibration such as vibration level 3. After a certain period of time, the vibration is switched to a stronger vibration such as vibration level 10. Alternatively, the system is switched to a method in which the vibration intensity of the shaking table 20 is feedback-controlled so that the emission amount h per unit time becomes constant, centering on a strong vibration such as a vibration level 10.

In addition, when the drug is difficult to be discharged such as "flow coefficient 3" and the total discharge amount is large such as discharge amount 80, vibration is started with strong vibration such as vibration level 11 for a certain period of time. After that, the vibration is switched to a stronger vibration such as vibration level 15. Alternatively, feedback control is performed so that the emission amount h per unit time becomes constant, centering on a strong vibration such as a vibration level 15.

Further, it is desirable to provide a verification function for verifying whether or not the weight measuring means 25 of the drug feeders 1 and 50 is accurate.
For example, a weight member having a known weight is prepared, and the weight is installed in the drug shelf region 103 or the like. Then, the weight member is moved to the shaking table 20 by the robot 43 or the like, and the weight of the weight member is measured by the weight measuring means 25. If the measured value matches the weight of the weight, the weight measuring means 25 is accurate, and if not, the weight measuring means 25 is out of order.
Further, the drug container 2 itself can be used as the weight member. For example, harmless powder or granules are placed in the drug container 2 and the weight thereof is measured in advance. The drug container 2 used as a weight member is installed in the drug shelf area 103 or the like together with other drug containers 2. Then, if necessary, the drug container 2 for the weight is moved by the robot 43 or the like, installed on the shaking table 20, and the weight measuring means 25 is verified.

The measure for installing the drug container 2 in the drug shelf region 103 is arbitrary, but for example, as shown in FIG. 47, a drug shelf 328 provided with a plurality of vertical walls 320 and a mounting table 323 can be considered. The vertical wall 320 is provided with an upper engaging portion 325, and the mounting table 323 is provided with a lower engaging portion 326. The upper engaging portion 325 and the lower engaging portion 326 are maintained in a protruding state by an urging member (not shown).
In the drug container 2 adopted in the present embodiment, in addition to the configuration of the drug container 2D of the fourth embodiment, the lid member 120D is provided with an engaging protrusion 370. In addition, there is a recess 371 at the rear end of the drug container 2D.
The upper engaging portion 325 rotates upward as shown by an arrow by pressing the lid member 120D of the drug container 2D. The lower engaging portion 326 is submerged in the mounting table 323 by pressing the iron plate portion 6 of the drug container 2.
When the drug container 2D is pressed against the drug shelf 328, the upper engaging portion 325 and the lower engaging portion 326 escape against the force of the urging member. Then, when the drug container 2D reaches a predetermined position, the upper engaging portion 325 returns by an urging member (not shown) and engages with the engaging projection 370 of the lid member 120D. Further, the lower engaging portion 326 is returned by an urging member (not shown) and engages with the recess 371 at the rear end of the drug container 2D.
When taking out the medicine container 2D, the medicine container 2D is held by a robot 43 or the like and separated from the medicine shelf 328. At that time, the upper engaging portion 325 and the lower engaging portion 326 escape against the force of the urging member, and the engagement is released.

Further, for example, as shown in FIG. 48, a drug shelf 345 provided with a plurality of vertical walls 340 and a plurality of mounting tables 343 can be considered. The vertical wall 340 has an opening 346, and a protrusion (upper engaging portion on the storage portion side) 347 projects upward in the opening 346.
Further, the mounting table 343 is provided with a lower engaging portion 348 on the storage portion side. The lower engaging portion 348 on the storage portion side is a protrusion.
In the present embodiment, the drug container 2 to be adopted has a recess 350 at the rear end like the drug container 2D of the fourth embodiment. A container-side engaging portion 352 is provided on the lower surface 12D of the peripheral wall of the container body 5D. The position of the container-side engaging portion 352 is the lower surface 12D of the peripheral wall and a position slightly closer to the lid member 120D than the center, and when the drug container 2D is installed on the shaking table 20, it does not hit the shaking table 20. The container-side engaging portion 352 has a ring shape and is provided with a square hole 351 penetrating in the longitudinal direction of the drug container 2D.

In the present embodiment, the container-side engaging portion 352 of the drug container 2D is inserted through the opening 346, the drug container 2D is pushed down, and the protrusion of the drug shelf 345 (the upper part of the storage section side) is formed in the hole 351 of the container-side engaging portion 352. The drug container 2D is suspended from the drug shelf 345 by inserting the joint portion 347.
At this time, the protrusion (lower engaging portion on the storage portion side) 348 provided on the mounting table 343 engages with the recess 350 of the drug container 2.

Among the drug containers 2 described above, in principle, the drug container 2 having a lid is charged with the drug by removing the lid member 120, but the drug container 2E of the fifth form has a movable lid portion 134E. Since it is easy to remove the lid, the drug can be added without removing the lid body 125E. In that case, as shown in FIG. 45, if the funnel-shaped member 355 is attached to the movable lid portion 134E and the work is performed, the drug does not easily spill.

1; drug feeder, 2A, 2B, 2C, 2D, 2E, 2F; drug container, 3; main body device 5; container body, 6; iron plate part, 7; rectifying member, 8; drug discharge part, 12; peripheral wall lower surface, 13; constriction opening, 15; storage space, 17; powder storage, 18; lead-out path, 20; shaking table, 21a, 21b; vibration means, 22; intermediate table, 23; vibration isolation table, 25; weight. Measuring means, 26; basic member, 30a, 30b; electromagnet (container holding means), 32a, 32b; elastic body, 33a, b, c, d; contact sensor, 35; vibration detection sensor, 40; vibration isolator, 50. Drug feeder, 152; Weight measuring means, 100; Drug dispensing device, 202; Powder distributor, 212; Distributor

Claims (13)

A drug container used for a drug feeder equipped with a main unit.
The drug container is removable from the main device of the drug feeder and is removable.
The drug container is vibrated by the main body device.
The drug container has a drug storage section for storing drugs and a drug discharge section for discharging drugs to the outside.
The drug discharging portion has an opening portion that communicates inside and outside, and has an opening portion.
There is a region serving as a passage for the drug between the drug storage portion and the opening portion of the drug discharge portion, and the tip side of the region is narrowed.
There is a stenotic opening between the area and the drug reservoir
It is possible to have a movable lid portion and to open the drug discharge portion by pressing the movable lid portion with a pressing piece and a state in which the drug discharge portion is closed.
By vibrating the medicament container, the medicament drug within the reservoir passes through the constriction opening enters the region to be a passage of the drug, the drug is laminarization, wherein the agent the medicine discharge section A drug container characterized by being discharged from. The movable lid portion swings around a shaft portion composed of a shaft or a shaft piece located below the upper end of the movable lid portion and above the opening portion.
The drug according to claim 1, wherein the upper end of the movable lid portion swings around the shaft portion and moves to the drug storage portion side when the drug discharge portion is opened. container. A shielding wall for sealing the drug is provided inside the drug container above the opening portion.
The drug container according to claim 2, wherein the upper end of the movable lid portion swings around the shaft portion and moves to the shielding wall side when the drug discharge portion is opened. A rectifying member is provided inside,
The rectifying member is arranged at a position where a part or all of the medicine passes when the medicine inside is moved to the medicine discharging part side.
With the rectifying member as a boundary, the region functions as a lead-out path portion, the drug is laminarized in the lead-out path portion, and the laminarized drug is moved along the lower surface of the peripheral wall of the container body to move the laminarized drug to the opening portion. The drug container according to any one of claims 1 to 3, wherein the drug container is discharged from the container. The movable lid portion has a knob portion and has a knob portion.
The drug container according to any one of claims 1 to 4, wherein when the knob portion is pushed by the pressing piece, the movable lid portion is opened. The movable lid portion has a knob portion arranged at one end and a holding plate portion connected to the knob portion at the other end to keep the drug discharge portion in a closed state and an open state. The drug container according to claim 5. The drug container according to claim 6, wherein the movable lid portion has a bearing portion that receives a shaft portion formed of a shaft or a shaft piece between the holding plate portion and the knob portion. .. At the time of storage, the drug container is placed on a container shelf for storing the drug container.
When the drug container is moved from the container shelf to the main body device on which the drug container is placed by the container moving means for moving the drug container, and the main body device is installed in a horizontal posture,
The drug container according to any one of claims 5 to 7, wherein when the knob portion is pushed by the pressing piece, the pressing plate portion is opened. The drug container according to any one of claims 1 to 8, wherein the drug container is placed in a vertical posture or an inclined posture on a container shelf during storage. The drug container according to any one of claims 1 to 9, wherein a transporting iron plate portion capable of being attracted by an electromagnet is provided at a position on the upper surface with respect to a horizontal posture. The drug container according to any one of claims 1 to 10, wherein the movable lid portion maintains a closed state by engaging with a leaf spring. The drug container according to any one of claims 1 to 11, wherein the drug container has an opening on the upper surface side with reference to a horizontal posture, and the drug can be charged into the inside through the opening. A coiled member is provided inside,
Claims 1 to 1, wherein the coiled member is provided at a position where a part or all of the drug is provided across the inside of the coiled member when the drug inside is moved to the drug discharging portion side. The drug container according to any one of 12.

Images